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Abstract  
 
A hernia frequently complicates abdominal stoma formation. The aetiology of parastomal 
herniation is claimed to be multi-factorial but currently only age and trephine diameter have 
been shown to independently predict its development. Open or laparoscopic repair of a 
symptomatic parastomal hernia is frequently challenging and is associated with 
unsatisfactory recurrence rates. As a result, many affected patients are managed non-
operatively.  
Prevention of parastomal herniation by prophylactic mesh reinforcement of the stoma site is 
a new strategy that may reduce its incidence. Manual mesh implantation, however, is 
thought to increase the operating time and is considered cumbersome, particularly in 
laparoscopic surgery. As a result, routine reinforcement of the stoma site is not currently 
standard practice within the National Health Service. Thus, there is a need for a simple and 
quick technique for stoma formation which avoids creating an oversized defect and 
simultaneously reinforces the trephine with mesh.  
The aims of this thesis included: (i) understanding the aetiopathogenesis of parastomal 
herniation, assessing its impact on patients’ quality of life and examining the outcomes 
associated with current therapeutic strategies in order to find novel therapies that may lead to 
its prevention; (ii) assessing the safety, reproducibility and efficacy of the Stapled Mesh 
stomA Reinforcement Technique (SMART) in preventing parastomal herniation and (iii) 
investigating the contribution of the rectus abdominis muscle to the development of 
herniation.  
A detailed literature review of PubMed and Medline databases confirmed that stoma 
formation through the rectus muscle is complicated by parastomal herniation in 50%-80% of 
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cases. Surgeons have underestimated its impact on patients’ quality of life. There is no 
conclusive evidence that alternative techniques (e.g. extraperitoneal, lateral rectus abdominis 
positioned stoma) are superior. Open and laparoscopic parastomal hernia repair have similar 
recurrence rates up to 50%. Prophylactic reinforcement of the stoma trephine with mesh in 
the sublay or subperitoneal position is safe and appears to reduce the herniation rate but it is 
difficult laparoscopically and does not address the issue of trephine size when a defect 
<25mm is associated with a reduced herniation risk.  
The Stapled Mesh stomA Reinforcement Technique (SMART) obviates the technical issues 
associated with routine stoma formation and reinforcement.  In a pilot study with patients at 
high risk for herniation, SMART was found to be safe and reproducible and reduced the 
herniation rate to 18%. Preliminary results of the international multicentre randomised 
controlled trial in all patients undergoing permanent stoma formation show that SMART 
reduces the herniation rate compared to the standard technique, without added morbidity and 
minimal impact on the operating time.  
A radiological study assessing the contribution of the rectus abdominis muscle into the 
development of parastomal herniation showed that the abdominal musculature undergoes 
postoperative changes consistent with atrophy with postoperative muscle density being  
higher in patients without parastomal herniation. 
In conclusion, at this moment in time, prophylactic mesh reinforcement should be offered to 
all patients undergoing elective permanent stoma formation. The SMART procedure has the 
potential to change current surgical practice. The contribution of the rectus muscle to the 
development of herniation warrants further research since improving muscle repair and 
regeneration may result in therapeutic benefits. 
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“Some degree of herniation around a stoma is so common that this complication may 
be regarded as inevitable “ 
                         
Professor John Goligher, 1984 
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1.1 Introduction 
An abdominal stoma (Greek for mouth) is a surgically created opening in the abdominal wall 
that allows exteriorisation of the gastrointestinal or urinary tract. Stomas may therefore be 
classified according to the organ they involve (i.e. gastrostomy, jejunostomy, ileostomy, 
colostomy or urostomy). Gastrointestinal stomas may be temporary or permanent. 
Temporary stomas are usually fashioned for feeding (e.g. gastrostomy, jejunostomy), to 
divert the faecal stream from a diseased bowel segment (e.g. loop ileostomy or colostomy) 
or to “protect” a gastrointestinal anastomosis prior to healing (e.g. defunctioning loop 
ileostomy covering a low rectal anastomosis). A permanent stoma (e.g. end ileostomy or 
colostomy) is created when restoration of gastrointestinal continuity is not technically 
feasible, carries a high risk for the patient or is associated with unacceptable functional 
outcome.  
Approximately 102,000 people are living with an abdominal stoma in the United Kingdom 
and around 20,000 new stomas are fashioned annually, of which 50% are permanent.
1 2
The 
most common complication of permanent stoma is parastomal herniation which may impact 
adversely not only on patients’ quality of life and psychological well-being but also on 
healthcare resources.
3-5
  
 The work in this thesis is concerned with herniation complicating permanent ileostomies 
and colostomies as temporary stomas are usually reversed within a period of six months with 
closure of the abdominal wall defect. 
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1.2 Abdominal herniation and theories of development 
A hernia is the protrusion of an organ or the fascia of an organ through the wall of the cavity 
that normally contains it.
6
 The abdominal cavity is the most common site for herniation with 
20 million such hernias repaired worldwide every year.
6
 Abdominal hernias develop through 
a hole or “defect” via which adipose tissue or abdominal organs covered by peritoneum may 
protrude. Conditions (e.g. obesity, pregnancy, ascites, chronic cough) that raise the intra-
abdominal pressure are thought to stretch or weaken the abdominal muscles and contribute 
to the development of such hernias. Examples of abdominal herniation include: 
(i) inguinal hernias (70-80% of all abdominal hernias) in which the inguinal canal is 
entered via a congenital weakness at the internal inguinal ring (indirect hernia) or an 
acquired weakness in the posterior wall (direct henia) 
(ii) umbilical/paraumbilical hernias (5-15% of abdominal hernias) which involve 
protrusion of intra-abdominal contents through a “defect” at the site of passage of 
the umbilical cord through the abdominal wall  
(iii) epigastric hernias (4-7% of abdominal hernias) that occur between the umbilicus and 
the xiphisternum in the midline 
(iv) femoral hernias (4-6%) occur below the inguinal ligament and are carry a greater 
risk of strangulation than inguinal hernias 
Abdominal herniation may also occur as a result of iatrogenic injury to the abdominal 
musculature and inadequate wound healing (e.g. incisional hernia, parastomal hernia).  
Longitudinal studies  have demonstrated that such hernias have increased  in frequency over 
the last three decades now accounting for at least 5% of all abdominal wall hernias.
6
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In the early 19
th
 century, the cause of herniation was thought to be a “mechanical disparity 
between the visceral pressure and the resistance of the abdominal musculature which was 
considered to be diminished by deficiency, debility or aging”.7 A common set of parameters 
(e.g. obesity, cough, constipation, pregnancy, etc) were considered causative but some 
investigators now suggest that these factors reveal rather than cause herniation.
7
 A 
significant discovery in 1964 was the increased incidence of herniation in rats with defective 
collagen formation.
8
 Further animal work involved the use of an iatrogenic agent (Beta-
amino-proprionitrile, BAPN) which inhibits collagen cross-linking making it less durable.
8
 
Conner and Peacock in 1973 showed that transection of the internal inguinal ring led to 
hernia formation in 20% of cases. With BAPN alone, 6-10% of animals developed a hernia. 
However, transection of the internal ring and addition of BAPN increased the herniation 
incidence to  90%.
9
 It became apparent that chemical mechanisms, as well as mechanical 
pathways, are important etiological factors in hernia development.  
Chemically-mediated mechanisms of hernia formation are likely to involve altered collagen 
metabolism and impaired wound healing. In normal wound healing, an inflammatory 
response is initiated and blood fills the defect allowing proteins to form a provisional 
scaffold which directs incoming cells and organises the remodelling of the scar tissue. 
Fibroblasts are subsequently recruited to the area where they initiate and promote 
angiogenesis, collagen synthesis, extracellular matrix formation and granulation tissue.  The 
latter is then remodelled and combined with foreign body giant cells to become fibrous scar 
tissue.
10
   
Collagen is the end-product of fibroblastic activity with Type I and Type III having been 
implicated in wound healing and hernia formation.
11 12
 Type I is predominant in mature, 
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stronger wounds while the soluble, non-polymeric Type III dominates the early-stages of 
wound healing. The ratio of Type I/Type III defines the strength of the collagen strand, the 
fibril diameter and bundle architecture. A decreased ratio (less Type I or more Type III) is 
associated with herniation
13
  and has been linked to increasing age, smoking and genetic 
disorders (e.g. Marfan’s syndrome ,  Ehlers-Danlos).7 11 14 15 The quality and amount of 
collagen in the body is also affected by the presence and amount of proteolytic enzymes (i.e. 
collagenases) and the lack of anti-enzymes that inhibit collegenase action. Smoking is a 
potent activator of collagenases.
7
 Increased collagenase levels (e.g. metalloproteinase MMP2 
and MMP9) have been reported in chronic human wounds, in compromised healing and in 
the elderly. Metalloproteinase inhibitors produce significantly stronger wounds even without 
any increase in collagen deposition. 
16
 Furthermore, reduced levels of metalloproteinase 
inhibitors (e.g. TIMP-1, TIMP-2) have been linked to the late occurrence of herniation
17-19
 
Mechanical pathways involving a structurally and functionally impaired abdominal wall may 
also contribute to the progression of herniation. Skeletal muscle provides the bulk of the 
mechanical strength of the abdominal wall.
20
 Skeletal muscle fibre development and 
regeneration are similar processes which involve mononuclear myoblasts that line up parallel 
to one another and fuse to form multinucleated myotubes.  The myotubes undergo a 
maturation process with innervation and vascularisation to produce myofibers. Myofibers are 
then bound together by connective tissue to provide strength to the muscle and contract 
simultaneously when electrically stimulated resulting in voluntary movement.
21 22
 When 
injury occurs, skeletal muscle regeneration and repair begins with the activation of 
progenitor cells, known as satellite cells, which migrate to the site of the defect and 
proliferate. Within the defect they align parallel to the injured myofiber and fuse to form 
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new myotubes which again undergo innervation and vascularisation to become functional 
myofibers.
10
 Few studies have explored the association between hernia formation and 
muscle atrophy or degeneration.
23 24
 Muscle atrophy leads to loss of contractile force and 
loss of muscle mass with reduced abdominal wall thickness.
24 25
 In a rat animal model, 
hernia formation was associated with muscle atrophy, decreased cross sectional area and 
pathological fibrosis consistent with myopathic disuse atrophy. These changes occurred 
despite an increase in muscle collagen content suggesting a mechanical mechanism remote 
from chemically medicated pathways. 
23
 Interestingly, atrophic changes  were more 
reversible following tension-free mesh hernioraphy than primary suture repair.
26
 
 
1.3 Definition and incidence of parastomal herniation 
A parastomal hernia is an incisional hernia related to an abdominal wall stoma.
27 Its precise 
incidence is unknown since published studies utilise a variety of  clinical or radiological 
methodologies which have yet to be standardised  (e.g. valsava manoeuvre, ultrasound, 
computed tomography) with additional uncertainty generated by variable follow-up intervals 
and heterogeneous cohorts
28
. A meta-analysis has estimated the incidence to be in the region 
of 30% for end-ileostomies and approximately 50% for end-colostomies after a 10-year 
follow-up period
27
. Studies have, however,  reported the appearance of parastomal herniation 
20 years post-operatively
5 and some surgeons believe it to be an inevitable consequence of 
stoma formation.
29 A colostomy appears twice as likely to herniate compared with an 
ileostomy. This could be related to the larger diameter of the trephine required to exteriorise 
the colon
27 30
 although a recent study interestingly found different para-colostomy and para-
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ileostomy herniation rates (46% versus 22% respectively) despite similar aperture sizes 
(median 30mm, range 20-50mm).
31
  
 
1.4 Aetiology and risk factors for parastomal herniation 
The development of parastomal herniation is associated with the presence of certain risk 
factors which may be classified as patient-related or surgery-related. Patient factors include 
increasing age, abdominal obesity, poor nutritional status,  corticosteroid use, increased 
intra-abdominal pressure (due to chronic cough, constipation, benign prostatic hypertrophy, 
ascites), connective tissue disorders (e.g. Ehlers-Danlos syndrome)  and other disorders that 
predispose patients to wound infection (e.g. diabetes mellitus).
31-35
 A risk-stratification 
scoring system that takes into account the presence and influence of any these factors on the 
development of herniation might be a useful clinical tool to be developed since it may allow 
different management strategies for patients at low, medium, and high risk for herniation.   
Surgical factors influencing the development of parastomal herniation include the diameter 
of the trephine, whether the stoma is constructed in an emergency setting and whether an 
intraperitoneal or extraperitoneal approach is used. 
5 27 36 37
 
Although insufficient evidence exists on the ideal trephine size for stoma formation, a defect 
of 3cm or more was found to be associated with a higher incidence of herniation.
31 38
 
Furthermore, for every millimetre increase in the aperture diameter, the potential herniation 
risk increases by 10%.
31 Traditional surgical teaching advocates creating a defect large 
enough to admit the tips of two fingers. This does not take into account the variability of 
surgeons’ hand size. In fact, the average glove size of general surgeons is 7.5 39 which 
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equates to the creation of an abdominal wall defect 3.5cm in diameter. Aperture size greater 
than 3.5cm has been found to be an independent predictor of hernia development on 
multivariate analysis,
31
 thus the most common surgical technique frequently creates an 
oversized defect and does not allow the formation of a precise trephine according to the 
diameter of the exteriorised bowel segment.  
Resnick first described the use of a mechanical device in an attempt to “control” the size of 
the abdominal trephine. The device consisted of three different size disposable heads (17, 25 
and 32mm diameter) with a cartridge containing an annular knife and conical anvils.
40
 The 
device allowed the creation of a precise abdominal defect with only one case of herniation 
out of 32 patients reported with a mean follow up of 7 years.
41
 Other investigators have since 
used a circular stapler to construct colostomies with relative success.
42 43
It is clear that 
although the optimum diameter of the trephine is unknown, an oversized defect, frequently 
created by the current surgical technique, is not only undesirable but may contribute in itself 
to the development of herniation.   Circular stapling devices of various diameters may be 
advantageous in controlling the size of the abdominal wall defect. Their potential therapeutic 
value has not been assessed by randomised controlled trials.  
Stoma formation via a trans-peritoneal or extra-peritoneal approach warrants further 
discussion. Goligher first described the extra-peritoneal stoma in 1958 and reported a 
herniation rate of only 9% with a follow-up of at least 2 years.
44 45
 Other studies reported that 
extra-peritoneal colostomy provided some protection against para-colostomy herniation but 
only one study demonstrated a statistically significant difference.
5 46
 A recent meta-analysis 
of 1,071 patients comparing the extra-peritoneal versus the intra-peritoneal route for 
permanent colostomies found a lower parastomal herniation rate in the extra-peritoneal arm 
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(odds ratio=0.41, 95% confidence interval=0.23-0.73, p=0.002)
47
 There is, currently, 
insufficient level I evidence to advocate routine use of the extra-peritoneal technique since it 
is technically more difficult and time consuming, especially in a laparoscopic scenario, and 
requires further colonic mobilisation to provide extra length for the extra-peritoneal course. 
Furthermore, there are still concerns regarding the functional outcome of the stoma and the 
possibility of obstruction as the intestine follows its extra-peritoneal course.  
The trans-peritoneal approach has been the most popular method of stoma formation over 
the last two decades.
48
 This approach allows stoma formation either directly through or 
lateral to the rectus muscle. Sjodahl et al investigated the incidence of parastomal herniation 
in patients with permanent intestinal stomas formed either directly through or lateral to the 
rectus muscle. One hundred and seven patients had a stoma formed through the rectus 
abdominis with 23 patients lateral to it. The incidence of parastomal herniation was 2.8% 
and 21.6 % respectively.
49
 Other studies have not confirmed these findings.
5 36 50
 
Furthermore, Stephenson and colleagues reported that the lateral rectus abdominis positioned 
stoma (LRAPS) was associated with only 10% parastomal herniation rate in 41 patients with 
a mean follow up of 23 months (range 19-29).
51
 Despite the lack of sufficient evidence, 
stomas are routinely fashioned through the rectus muscle since this technique is not 
associated with any disadvantages.
1
 Splitting and  excessive stretching of the rectus fibres, 
however, is likely to damage and weaken  the muscle and may be an important factor in the 
pathogenesis of herniation. Moreover, injury to the epigastric nerves, which supply the 
rectus abdominis muscles, as a possible mechanism has not been previously considered. 
Partial or complete nerve transection may lead to denervation of the rectus abdominis with 
resulting muscle atrophy and abdominal wall weakness.
52 53
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Emergency surgery has always been thought to increase the likelihood of parastomal 
herniation as the intraoperative trephine diameter often needs to be larger to safely 
exteriorise an obstructed dilated bowel segment and also because the finer technical aspects 
of stoma formation are not always the priority in life threatening emergency situations. 
Interestingly, a retrospective study evaluating transverse colostomies in 251 patients did not 
find any difference in parastomal herniation rates between emergency and elective surgery.
54
 
Other studies reported herniation rates of 2-4% for stomas formed in an emergency 
situation.
55 56
  These figures are inconsistent with those most widely quoted in the literature 
and difficult to explain. They could, however, be related to patients lost to follow-up because 
of the higher mortality associated with emergency surgery or the fact that a certain number 
of stomas are reversed within months from the primary operation. For example, Mealy et al 
reported parastomal hernia incidence of 2.7% in 73 patients who underwent emergency 
stoma formation but the follow up time was not mentioned and the stoma closure rate was 
around 60%. 
56
 
 In conclusion, the most popular surgical technique of stoma formation has several technical 
limitations including inability to create a consistent trephine diameter with potential damage 
to the rectus muscle and its associated blood/ nerve supply. All these may contribute to the 
high rates of parastomal herniation.  
 
1.5 Diagnosis of parastomal herniation 
Parastomal hernias can be diagnosed by clinical examination with the subject either supine 
with legs elevated or standing being asked to cough or strain.
57
 The aim of the examination 
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is to demonstrate a positive cough impulse or palpable defect adjacent to the stoma. In 
patients with small parastomal hernias and/or abdominal obesity, clinical assessment may be 
difficult and equivocal. Computed tomography (CT)  may be used, if clinically indicated, to 
increase the diagnostic accuracy. This also allows pre-operative classification to be made.
36
 
CT assessment with the patient in the prone position has been suggested in one study to 
improve the clinical and radiological reproducibility and correlation.
58
 This is due to the 
hernia becoming more obvious due to gravity. 
 
1.6 Classification of parastomal herniation 
Devlin was the first person to classify parastomal hernias into 4 clinical subtypes
59
:  
(i) subcutaneous, the hernia sac lays in the subcutaneous tissues,  
(ii)  interstitial, the hernia sac is within the abdominal wall layers,  
(iii) peristomal, a bowel segment prolapses through a circumferential sac surrounding 
the stoma and  
(iv) intra-stomal, as in case of ileostomies, the hernia sac is positioned between the 
intestinal wall and the everted intestinal layer.  
The complexity of this system has limited use in surgical practice together with the abscence 
of data correlating the above subtypes with symptoms and surgical outcomes has made this 
classification impractical to use. A new radiological classification has been proposed by 
Moreno-Matias et al involving three subtypes according to the contents of the hernia sac: (i) 
type I, the hernia sac contains the stoma loop, (ii) type II, the hernia sac contains omentum 
and (iii) type III, the sac contains a bowel loop other than stoma.
60
 Similarly, the usefulness 
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of such a classification system in surgical practice is debatable. Consequently, clinicians 
prefer to simply classify parastomal hernias as symptomatic and asymptomatic which has 
implications for the management of such patients.  
 
1.7 Symptoms and Quality of life (QoL) with parastomal herniation. 
Several studies have reported that stoma formation has a negative impact on quality of life 
(QoL).
61-67
 It is thought that parastomal herniation has an even greater detrimental effect 
because it causes further change in body image and cosmesis, increased pain, difficulty with 
stoma appliance application resulting in leakage of bowel contents, obstruction and 
incarceration. Only two studies have assessed the effect of parastomal herniation on QoL. 
Kald et al used disease-specific and stoma-specific questionnaires to report a statistically 
significant reduction in QoL of patients with a parastomal hernia compared to patients 
without herniation.
68
 Another study assessed, using regression modelling, predictors of poor 
quality of life in patients with diverting loop ileostomy after restorative proctocolectomy. It 
showed that parastomal herniation was a significant predictor of impaired QoL.
69
  
Additional evidence supporting the hypothesis that parastomal herniation is associated with 
impaired QOL scores is provided by studies assessing patients with incisional hernias who 
did not undergo stoma formation.  In a non-randomised study by Thaler et al, patients with 
incisional hernia after open or laparoscopic colectomy had significantly worse SF-36 scores 
for the domains of physical functioning, general and mental health and social functioning 
compared to patients without herniation.
70
 Cheatham et al reported that patients with 
massive incisional hernias following abdominal decompression for intra-abdominal 
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hypertension demonstrated significantly decreased perceptions of physical, social and 
emotional health in comparison to the general population.
71
 
Nevertheless, there is a paucity of high quality evidence assessing the impact of parastomal 
herniation on QoL. This highlights that surgeons have underestimated the effect of such a 
hernia on patients and may explain why little progress has been made in the reduction of this 
complication over the last few decades.  
 
1.8 Treatment of symptomatic parastomal hernias. 
1.8.1 Open parastomal hernia repair 
Patients with parastomal hernias require surgical repair in 11-70% of cases with most studies 
reporting rates of approximately 30%.
37 72
 
  
Pain and limitation of daily activities are 
considered by surgeons the most important indications for incisional/parastomal hernia 
repair whereas cosmetic complaints are viewed as less significant.
73
  Nonetheless, current 
surgical techniques such as primary fascial repair or complete resiting of stoma are 
associated with very high recurrence rates and have the potential for significant morbidity 
and mortality.
27 37
 Local aponeurotic repair recurrence rates range between 45% and 75%.
74-
76
 Stoma repositioning carries the morbidity and mortality associated with a major 
laparotomy and the recurrence rates are equally disappointing at approximately 50%.
1,3,24,26 
Furthermore, resiting of the stoma may result in an additional incisional hernia at the site of 
the original stoma or the midline wound.
77 78
 These procedures should not be routinely 
performed. 
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Following the success of mesh repair for other types of hernia, the technique of mesh 
reinforcement has naturally led to its use for the treatment of parastomal hernias.
79-101
 
Several techniques have been described involving implantation of the mesh in an on-lay, 
sublay, pre-peritoneal or intra-peritoneal plane in relation to the abdominal wall layers 
(Figure 1.1). The fascial onlay technique requires suturing the mesh to the anterior rectus 
sheath; the sublay (retromuscular) approach involves positioning the mesh between the 
rectus muscle and the posterior rectus sheath; the pre-peritoneal approach requires separation 
of the peritoneum and posterior rectus sheath and placement of the mesh in between and, 
finally, intra-peritoneal mesh placement involves attachment to the visceral peritoneal 
surface.  
The fascial onlay technique was first described by Rosin and Bonardi more than 30 years 
ago
90
 and since then studies with relatively poor methods of assessment (Level IV) have 
reported variable results with this technique (Table 1.1, page 32).  In general, recurrence 
rates vary between 0 and 62.5% with the largest studies reporting rates of between 8% and 
26%. In addition, infection rates are between 0 and 12.5% in the largest series with the mesh 
removal rates between 0 and 23%. In one of largest series with the longest mean follow up, 
the recurrent herniation rate for stomas reinforced with a polypropylene ring prosthesis was 
16% but more importantly the mesh  removal rate was the highest reported at 23%.
81
Overall, 
the onlay mesh reinforcement technique appears to be safe with acceptable infection rates 
and lower recurrence rates compared with fascial repair or stoma resiting. Further long- term 
studies are, however, required to assess the mesh explantation rate. The attraction of this 
technique is that a formal redo laparotomy may be avoided and should be considered in high 
risk patients with small/medium size hernias.  
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Figure 1.1 Diagrammatic illustration of mesh placement in relation to abdominal wall layers. 
 
 
 
  
 
 
Posterior rectus sheath 
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There are very few studies investigating mesh placement in the pre-peritoneal plane 
(between peritoneum and posterior rectus sheath) and sub-lay position (between rectus 
muscle and posterior sheath).
91-93
 The theoretical advantages of placing the mesh in this 
anatomical plane are that the peritoneum prevents contact with bowel and the rectus muscle 
and the anterior rectus sheath prevent mesh “lift-off”. Egun et al used pre-peritoneal mesh 
implantation without  any recurrences in a series of 10 patients with a mean follow up of 54 
months (range 22-69) but reported two superficial wound infections with one case of mesh 
explantation and subsequent stomal infarction.
92
 Longman and Thompson reported no 
recurrences or complications with a sub-lay technique in 10  patients with a mean follow up 
of 30 months.
91
 Kasperk et al also used a sub-lay technique but they reported 2 early 
recurrences among 7 patients which they attributed to technical errors (i.e. making mesh 
defect too large and using absorbable sutures that allowed mesh disruption).
93
 Overall, it is 
very difficult to draw any meaningful conclusions from such a small series of studies with 
relatively short follow up but there were 2 recurrences in 27 patients (7.4%) and 1/28 (3.6%) 
cases of mesh removal (Table 1.2, page 34).   
The intra-peritoneal approach was first described in 1980 by Sugarbaker who covered the 
fascial defect with a piece of synthetic mesh which was secured around its margin except 
laterally where the colon exited the abdominal cavity to form the ostomy.
100
 The excellent 
results produced by Sugarbaker have not been replicated by all other investigators (Table 
1.3). In a small series of 7 patients with a median follow up of 81 months, the recurrence rate 
was 28.6% and polypropylene mesh related complications included dense adhesions in 4 
patients (57%) necessitating a laparotomy for intestinal obstruction in one patient.
97
 In 
addition, one patient developed an intra-abdominal abscess 3 years post-operatively and the 
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mesh had to be removed with great difficulty because of the adhesions.
97
 The risk of 
polypropylene mesh for significant adhesions, bowel erosion and fistulation has led other 
investigators to use PTFE (polytetrafluoroethylene) mesh.  PTFE is a synthetic mesh which 
is softer, more pliable with smaller pores and appears less likely to cause bowel erosion and 
adhesions.
94 102 103 
The recurrence rate was between 0% and 15% but the studies all had a 
short follow-up (Table 1.3, page 35).  Importantly, complications such as adhesions, bowel 
erosion and fistulation were not reported. However, PTFE has pores measuring less than 
10μm with the potential for infection as they could harbour bacteria.94  Longer term follow 
up studies are required to assess its infective complications.  
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        Table 1.1 Outcomes following on lay mesh repair for parastomal hernia. Studies listed in chronological order. 
 
Study Year 
Level of 
Evidence 
No 
Repairs 
% 
Recurrence 
% 
Infection 
% 
Erosion 
% 
Mesh 
Removal 
Follow up 
(mean) 
Type 
of assessment 
Luning
79
 2009 IV 16      19.0 6.2 0.0 6.2 6-110            
(33) 
not stated 
Guzman-
Valdivia
80
 
2008 IV 25 8.0 8.0 0.0 0.0 8-24              
(12) 
clinical 
De Ruiter
81
 2005 IV 46 15.9 6.6 - 22.7 12-156          
(60) 
clinical 
Kanellos
82
 2004  IV 4 0.0 0.0 0.0 0.0                   
(36) 
not stated 
Steele 
83
 2003 IV 58 26.0 3.4 2.0 0.0 0.2-139         
(50.6) 
clinically 
Geisler
84
 2003 IV 16 62.5 12.5 6.2 6.2 2-161            
(39) 
Phone survey+ 
case notes 
Venditti
101
 2001 IV 8 0.0 12.5 0.0 0.0 (36) not stated 
Amin 
85
 2001 IV 9 0.0 0.0 0.0 0.0 3-12              
(6) 
not stated 
Kald
86
 2001 IV 5 20.0 0.0 0.0 0.0                      
(12) 
not stated 
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Tekkis
87
 1999 IV 5 0.0 0.0 0.0 0.0 9-38                
(21.4) 
Not stated 
Bayer 
88
 1986 IV 7 0.0 28.5 0.0 14.3                      
(48) 
not stated 
Abdu 
89
 1982 IV 5 0.0 20.0 0.0 0.0     24-48     not stated 
Rosin 
90
 1977 IV 7 0.0 0.0 0.0 0.0       3-48     not stated 
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         Table 1.2. Outcomes following sub-peritoneal mesh repair for parastomal hernia. 
Study Year 
Level of 
Evidence 
No 
Repairs 
Mesh 
position 
% 
Recurrence 
% 
Infection 
% 
Erosion 
% 
Mesh 
Removal 
Follow 
up 
(mean) 
Type 
of follow 
up 
assessment 
Longman
91
 2005 IV 10 sublay 0.0 0.0 0.0 0.0 
2-40           
(30) 
Case 
notes+ 
patient 
contact 
Egun
92
 2002  IV 10 Preperitoneal 0.0 20.0 0.0 10.0* 
22-69         
(54) 
not stated 
Kasperk
93
 2000 IV 7 Sublay 28.6§ 0.0 0.0 0.0 4-36 not stated 
        * For  stomal infarction post ARDS,      §due to technical error 
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 Table 1.3. Outcomes following intraperitoneal mesh placement. 
*Polytetrafluoroethylene  mesh,                      ¶ one laparoscopic excluded         § median,  
Study Year 
Level of 
Evidence 
No 
Repairs 
Mesh 
% 
Recurrence 
% 
Infection 
% 
Erosion 
% 
Adhesions 
% 
Mesh 
Removal 
Follow 
up 
(mean) 
Type of 
follow up 
assessment 
Ballas
94
 2006 IV 2 PTFE 0.0 0.0 0.0 0.0 0.0 
24-60        
(42) 
CT 
Van 
Sprundel
95
 
2005 IV 15¶ PTFE 13.3 0.0 0.0 0.0 0.0 
5-52          
(29)§ 
clinical 
Stelzner
96
 
2004 IV 20 PTFE* 15.0 5% 0.0 5.0 0.0 
3-84          
(42) 
Clinical ±  US 
± case notes 
Morris -Stiff
97
 1998 IV 7 Polypropylene 28.6 14.3 0.0 57.0 14.3 
60-89        
(81)§ 
not stated 
Hofstetter
98
 1998 IV 13 PTFE* 0.0 0.0 0.0 0.0 0.0 
Over 
96 
not stated 
Byers JM
99
 1992 IV 9 Polypropylene 0.0 11.1 0.0 0.0 0.0 (13.4) 
Retrospective 
case note 
review 
Sugarbaker
100
 1980 
IV 7 Polypropylene 0.0 0.0 0.0 0.0 0.0 48-84 not stated 
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1.8.2 Laparoscopic parastomal hernia repair. 
With the rising popularity of laparoscopic surgery over the last two decades, its use has 
spread to the treatment of parastomal hernias.
104-117
  The rationale is that the laparoscopic 
approach is associated with minimal additional injury to the abdominal wall and potentially 
offers a superior view of the defect allowing more precise repair and reinforcement with a 
mesh.
106 107
 Several investigators have reported their experience with laparoscopic 
parastomal hernia repair with variable success rates (Table 1.4). The conversion rates vary 
between 0 and 15%. Most laparoscopic repair studies report low wound infection rates of 0-
5% with low mesh explantation rates (up to 10%). The most popular mesh in the 
laparoscopic studies was the Polytetrafluoroethylene (PTFE) which may account for the very 
low rate of erosion between 0 and 1.5% (Table 4). Although PTFE is a soft, inert material 
with minimum reactivity that does not adhere to bowel,
103
  its major drawback appears to be 
its tendency to shrink,
106 107 
which accounts for the disappointing recurrence rates of up to 
46% (Table 1.4, page 39). The shrinking of  PTFE mesh is thought to be due to the small 
pore size of the mesh which prevents tissue in-growth and incorporation (see section 
1.10.2).
102
 Hansson and colleagues reported that in almost all patients in their series who 
were re-operated for a recurrent parastomal hernia, the mesh appeared smaller with a wider 
central opening which was likely to be the cause for the recurrence.
107
 This is clearly an 
important observation since their series is one of the largest with a median follow up of 36 
months. The ability of the PTFE mesh to provide effective, long term treatment for 
parastomal hernias is in doubt and warrants further investigation. Other investigators have 
used instead of the “keyhole” technique, variations of the “Sugarbaker technique” that 
avoids creating a central hole with a slit in the mesh.
 
Mancini et al reported recurrence rates 
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of 4% with this technique
112
 whereas Pastor et al 
108 
reported recurrence rates of 29% using 
the modified ‘Sugarbaker’ technique  and 67%  using a ‘keyhole’ technique. Similarly, 
Berger and Bientzle reported 8 recurrences in 41 patients (19.5%) using the modified 
‘Sugarbaker’ technique which they thought was disappointing. Subsequently, they used a 
two-mesh sandwich technique in the next 25 patients with no reported recurrences but the 
median follow up was only 12 months.
110  
An increasing number of symptomatic parastomal hernias may be repaired laparoscopically. 
However, the ability of PTFE, which has been the mesh of choice in the published literature, 
is in doubt because it shrinks by almost 50% and has the potential to cause long-term septic 
complications.
118
 One way of possibly reducing the risk of infectious complications is by 
using antimicrobial impregnated meshes.
119
 The problem of mesh shrinkage can possibly be 
addressed by the use of composite meshes commonly made of polypropylene and PTFE 
although other materials such as polyvinylidene fluoride (PVDF), cellulose and omega-3 
fatty acids have been used. The PTFE interface allows safe intra-peritoneal placement with 
minimal adhesion formation and the additional surface ensures strong adherence to the 
abdominal wall by inducing a fibrotic reaction.
118
 However, the long term results with such 
meshes are not known. There is also evidence that adhesions are prevented in the short term 
but the effect diminishes with time.
120
 In addition, the two layers can become separated 
allowing bowel adherence.
121
  
In conclusion, the laparoscopic approach appears attractive in view of the theoretical 
advantages of a more precise repair, minimal injury to the abdominal wall and faster 
postoperative recovery with decreased postoperative pain. Nevertheless, patients 
occasionally may complain of pain from the tacking sutures or clips to the abdominal wall. 
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Laparoscopic parastomal hernia repair is associated with similar results to open repair and, 
hence, the benefit of this approach is unclear in terms of the longevity of repair considering 
the reported problems with mesh shrinkage and surgical repair technique. If a laparoscopic 
approach is selected then “Sugarbaker/modified Sugarbaker” or “Sandwich” techniques 
should be the preferred therapeutic options, since, at the present time, they appear to be 
superior compared to the “keyhole” technique.  
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Table 1.4. Recurrence and complication rates following laparoscopic  mesh placement 
Study Year 
Level of 
Evidence 
No 
Repairs 
% 
Conversion 
Type of Mesh Technique 
% 
Recurrence 
% 
Infection 
% 
Erosion 
% 
Mesh 
Removal 
Follow 
up 
(mean) 
Type of 
follow up 
assessment 
Mizrahi H104 
 
2011 
 
IV 29 
 
6.9% 
 
PP§/PTFE 
 
Keyhole 
 
46.4 
 
3.4 
 
0.0 
 
3.4 
 
12-53 
(30)* 
 
Clinical ± CT 
if available 
Wara105 2010 IV 66 4.0 PTFE/PP Keyhole 3 4.5 1.5 6.0 6-132 
(36)* 
Clinical + CT 
if in doubt 
Hansson  106 
107 
2009 IV 54 14.5 PTFE Keyhole 37 1.8 0.0 3.7 12-72 
(36)* 
Clinical ± 
CT/US 
Pastor 108 2009 IV 12 8.3 PTFE Keyhole/Sugarbaker 33.3 16.6 0.0 0.0 (13.9) not stated 
Muysoms109 2008 IV 24 0.0 Polyester/PTFE 
/PP 
Keyhole/Sugarbaker 41.7 0.0 0.0 0.0 4-54  
(21.2) 
clinically ± 
CT 
Zacharakis11
7 
2008 IV 4 0.0 PTFE Keyhole 25% 0.0 0.0 0.0 9*  
   clinical 
Berger 110 2007 IV 66 1.5 PVDF¶/PP Sugarbaker/”Sandwich” 12 4.5 0.0 3.0 3-72 
(24)* 
not stated 
Craft 111 2007 IV 21 0.0 PTFE Keyhole/Sugarbaker 4.7 4.8 0.0 9.5 3-36 
(14) 
Case notes 
review 
Mancini 112 2007 IV 25 0.0 PTFE Sugarbaker 4.0 4.0 0.0 4.0 2-38 
(19)* 
Clinical 
Le Blanc 113 2005 IV 12 0.0 PTFE Keyhole/ Sugarbaker 8.3 0.0 0.0 0.0 3-39 
(20) 
not stated 
Safadi114 2004 IV 9 0.0 PTFE Keyhole/slit 44.4 0.0 0.0 0.0 6-33 clinical 
Kozlowski 
115 
2001 IV 4 0.0 PTFE Modified Sugarbaker 0.0 0.0 0.0 0.0 2-33 clinical 
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Voitk116 2000 IV 4 0.0 Polyprolene Sugarbaker 0.0 0.0 0.0 0.0 2-12 not stated 
 
*median     §Polypropylene       ¶polyvinylidene fluoride 
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1.8.3 Emergency parastomal hernia repair 
There is a paucity of data in the literature regarding emergency parastomal hernia repair. No 
studies have been identified that have specifically evaluated outcomes following emergency 
treatment for incarcerated or strangulated parastomal hernias. Such an operation has the 
potential for significant morbidity and mortality
122
 and frequently requires a laparotomy, 
bowel resection and stoma resiting which, as mentioned previously, is associated with high 
recurrence rates.  The majority of surgeons would commonly avoid using a synthetic mesh 
in the presence of intestinal ischemia and bowel resection but studies evaluating emergency 
paraumbilical, incisional and inguinal hernia repair with mesh have reported good outcomes 
with low post-operative complications.
123-125
 
126
 The safety of synthetic meshes for 
emergency parastomal hernia repair requires further evaluation but this is a situation where 
biological meshes may potentially be advantageous in view of their ability to be used in 
infected or contaminated fields.
127
 This may be off-set by their significant economic cost at 
present. 
 
1.9 Prevention of parastomal herniation 
The high incidence of parastomal herniation together with the unsatisfactory results of its 
repair and morbidity associated with any corrective operation has led to a novel approach 
with emphasis on prevention. Consequently, some investigators have instituted the use of a 
“prophylactic” mesh at the time of the initial operation to prevent the development of 
herniation.
128-130
 Three randomised controlled trials have shown that implantation of a 
prophylactic mesh in the pre-peritoneal or sublay position is associated with a reduction in 
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parastomal herniation when compared to standard unreinforced stoma formation.
72 131 132
  
Two studies used a synthetic mesh (Vypro
® 
or Ultrapro
®
) to reinforce the stoma trephine in 
patients with permanent end colostomies.
72 132
 In the third study, a porcine collagen implant 
(Permacol
®
) was used to reinforce the trephine in patients with defunctioning loop stomas.
131
 
(Table 1.5) 
A recent meta-analysis
 
showed that the herniation rate in patients with synthetic mesh 
reinforced end-colostomies (8 of 55, 14.5%) was lower when compared to the standard 
group (32/54, 59.2%, RR 0.24, 95%CI 0.05 to 1.22; p=0.08).
133
 Similarly, the percentage 
herniation in Permacol
® 
reinforced loop ileostomies (0/10, 0.0%) was lower than the 
conventional group (3/10, 30%, RR 0.14, 95% CI 0.01 to 2.45; p=0.18). More importantly, 
there was a reduction in the percentage of clinically detected parastomal hernias requiring 
surgical treatment. Thirteen percent of patients with conventional end colostomy underwent 
repair of parastomal hernia compared to none in the reinforced group (RR 0.13, 95%CI 0.02 
to 1.02; p=0.05).  There was no difference  in stoma related morbidity or mortality.
133
 
Evaluation of morbidity is particularly important because there is concern among surgeons 
regarding the use of synthetic mesh near bowel as there is a perceived risk of septic 
complications from bacterial contamination of the mesh, adhesions, intestinal obstruction 
and fistulation.  Two studies did not report any mesh related infections or mesh 
explantation.
72 131
 One study reported three midline laparotomy wound infections in the 
mesh group (3/27, 11.1%) but the overall infection rate was identical to the conventional 
group (3/27, 11.1%) and no mesh had not be removed. Stoma related morbidity (e.g. 
peristomal infection, necrosis) was also similar in both groups.
132
 Thus, the evidence 
demonstrates that mesh rejection does not appear to be a major issue. This may be partly 
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attributed to the new generation of biologic or synthetic meshes which are better 
incorporated by the tissues and are more resistant to bacterial infection.
4
 Placement of the 
mesh in the pre-peritoneal or sublay position protects the mesh from bacterial contamination 
and minimises contact with the bowel, thus further decreasing the risk of infection, 
adhesions or fistulation.  
Prophylactic reinforcement of the abdominal wall trephine with a mesh appears to be a 
promising possible solution to parastomal herniation. The results of the previously reported 
randomised controlled trials should be interpreted in the context of important limitations. 
Serra-Arracil et al reported a 26% reduction in the clinical  incidence of herniation in the 
treatment group but patients were excluded from the study if they had a BMI>35, cirrhosis, 
COPD and corticosteroid treatment.
132
 In fact, it is these high risk factors which are 
associated with parastomal/incisional herniation. In addition, the study by Hammond et al 
had small numbers with a median follow up of only 6.5 months.
131
 Finally, in Janes’ study 
the herniation rate in the control arm was high (81%), the drop-out rate was 6/27(22.2%) in 
the control group but double in the mesh group (12/26, 46.15%) and the radiological 
incidence of herniation was not reported.
72
 Synthetic meshes (e.g. Vypro®, Ultrapro®) have 
been shown to reduce the incidence of parastomal herniation without added morbidity and 
are relatively inexpensive.
72 132
 There is limited evidence in the literature regarding the 
prophylactic use of biological meshes which are considerably more expensive but are 
thought to be less prone to infection due to their biocompatibility. The infection rates, 
however, following prophylactic reinforcement are low and, at the moment, the higher cost 
and lack of evidence regarding their relative efficacy over synthetic ones prohibits their 
routine use for prophylactic stoma reinforcement.  
Hotouras A, MD Thesis 2013 
 
 
4
4 
Table 1.5. Summary of RCTs assessing the effect of prophylactic mesh reinforcement on the prevention of parastomal herniation. 
Study Year 
Level of 
Evidence 
No of patients 
in each arm 
(standard 
versus mesh) 
Stoma 
Type 
Mesh type 
Mesh 
position 
(%) Clinical                    
Recurrence   
(standard 
versus mesh) 
Stoma 
related 
morbidity 
Hammond
131
 2008 II 10 vs 10 
Loop 
ileostomy 
Permacol® 
Between 
peritoneum 
and rectus 
sheath 
30.0 vs 0.0 
None 
reported 
Janes
72
 2009 I 27 vs  27 
End 
colostomy 
Vypro® sublay 81.0 vs 13.3 
None 
reported 
Serra-
Aracil
132
 
2009 I 27 vs 28 
End 
colostomy 
Ultrapro® sublay 40.7 vs 14.8 
7.4% both 
arms 
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1.10. The ideal surgical mesh  
The ideal mesh for the treatment or prevention of parastomal herniation is currently 
unknown. In theory, the chosen material should be sterile, non carcinogenic with adequate 
strength to resist increased intra-abdominal pressures while it stimulates tissue remodelling 
and regeneration.  It should also be “biocompatible” with the surrounding tissues by 
producing a favourable interaction between host and implant without causing acute/chronic 
inflammation or seroma formation. From a surgical prospective it should also have the 
following properties: 
 Easy to handle 
 Antibacterial and  resistant to chronic infection 
 Promote tissue re-growth and re-modelling while preventing bowel adhesion and 
fistulation 
 Inert with minimal contraction  
 Available at a reasonable cost for routine use 
 
 
1.10.1. Types of surgical meshes  
Over the last 30 years numerous materials have been described for hernia repair with more 
than 70 meshes now available on the market for abdominal wall reconstrustion.
134 135
 Such 
mesh implants can be classified as synthetic (absorbable or non-absorbable) or biological.  
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1.10.2 Synthetic meshes 
1.10.2.1 Non-absorbable (permanent) meshes 
Permanent meshes can be classified according to composition, filament structure 
(monofilament or multifilament) and pore size (microporous <75μm or 
macroporous>75μm). They are all manufactured from three basic surgical materials: 
monofilament polypropylene, multifilament polyester and expanded polytetrafluoroethylene 
(ePTFE) in combination with each other or with a range of other materials such as titanium, 
omega-3, and hyaluronate. Monofilament polypropylene was first introduced in the 1960s 
and still remains the most commonly used material for surgical meshes because of its 
hydrophobic nature and resistance to bacterial colonisation.
136
 Monofilament meshes offer 
the advantages of high tensile strength with low infection rates but they are rigid with 
decreased abdominal wall conformity.
137
 Multifilament meshes are less rigid but more prone 
to infection.
138
 Macroporous meshes allow greater tissue in-growth and biocompatibility but 
are more likely to produce adhesions. Microporous implants are less adhesiogenic due to the 
fact that they become encapsulated but they are more prone to infection as the small pores 
cannot be assessed by macrophages. 
118
 
The original thinking behind the use of a mesh was that the material should be very strong to 
reinforce the abdominal wall while inducing a fibrotic reaction and scar tissue formation.
118
 
Meshes such as Marlex®, Surgipro®, Prolene® (monofilament polypropylene) and 
Dacron®, Mersiline® (multifilament polyester) are heavy-weight, macroporous and they 
produce an intense fibrotic reaction with the potential for  pain, movement restriction and 
bowel complications (e.g. adhesions, fistulation).
118 139-141
 It became apparent that the surface 
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area, and hence strength of the mesh, had to be reduced. Calculations of the intra-abdominal 
pressure revealed that this was possible without compromising mesh function since the 
required tensile strength to withstand maximum abdominal pressure is only a tenth of that of 
most meshes.
142 143
 This led to the concept of light-weight, partially absorbable meshes such 
as Vypro® (polypropylene interwoven with absorbable Vicryl) and Ultrapro® 
(polypropylene interwoven with Monocryl). The light-weight meshes stimulate a reduced 
inflammatory reaction with greater biocompatibility. They also shrink less (Vypro shrinks 
29% and Ultrapro <5% ) and are associated with less pain, bowel adhesion, erosion and 
fistulation.
118
 Despite these improvements, many surgeons remain wary of such implants in 
close proximity to the bowel.   
The search for the “ideal” mesh led to the development of alternatives such as expanded 
polytetrafluoroethylene (ePTFE) and composite meshes. ePTFE (GoreTex®, MycoMesh® 
and DualMesh® ) is inert, hydrophobic and its implantation produces less severe  
inflammatory reaction and tissue ingrowth than polypropylene.
144 145
 Furthermore, its 
microporous nature means that it becomes encapsulated, thus allowing intraperitoneal 
placement. However, it shrinks by 40-50% with time accounting potentially for weaker 
hernia repair (please see section 1.8.2, Laparoscopic parastomal hernia repair) and is 
associated with higher incidence of infective complications.
118
 Its encapsulation and small 
pore size (<10μm) prohibit the host immune system from reaching harboured microbes, thus 
necessitating mesh removal when infection occurs.
118 144 146 147
 Its use in contaminated or 
potentially contaminated fields is not recommended. Manufacturers have attempted to 
improve the properties of PTFE mesh by producing variations with full-thickness pores 
(MycoMesh®), with a textured parietal surface to improve tissue incorporation 
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(DualMesh®) and with an antibacterial coating (DualMesh® Plus). There is no evidence that 
these products alleviate the concerns associated with the use of PTFE.
148
 
Composite meshes consist of a visceral and a parietal surface with the former permitting safe 
intraperitoneal placement with reduced adhesiogenesis and the latter promoting tissue in-
growth and intergration.
118
 The parietal surface usually consists of polypropylene and the 
visceral surface of PTFE (Composix®), PVDF (polyvinylidene fluoride,; Dynamesh® ) or a 
cellulose-based material (Proceed®, Sepramesh®). The long-term results with composite 
implants are unknown with some studies showing that, despite their use, bowel 
complications such as adhesions still occur. This may be related to the surgical technique 
used for mesh fixation, a diminished anti-adhesional effect with time or separation of the two 
layers at the edges and exposure of the polypropylene layer to the bowel.
149
  
 
 
1.10.2.2 Absorbable meshes 
Absorbable meshes contain glycolic acid  and (poly)lactic acid compounds at different ratios 
and their degradation increases with increased glycolic acid content.
150
 The most commonly 
used absorbable mesh is made of polyglactin (Vicryl), a combination of glycolic and lactic 
acids in a ratio of 9:1. This mesh loses 50% of its strength within 2-3 weeks whereas an 
implant made predominantly of lactic acid (95% lactic acid and 5% glycolic acid) maintains 
its strength for at least 9 months.
151 152
Absorbable implants are thought to provide 
mechanical support in the acute phase with subsequent fibro-connective tissue formation 
taking over the repair in the long-term.
144
 In view of this property, they have excellent 
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biocompatibility and low risk of infective or bowel-related complications.
118 153
 Their 
theoretical advantages are not accompanied by satisfactory results with long-term data 
indicating that that they are not any better than simple suture repair.
144 154
 Furthermore, in an 
animal model, Tyrell et al did not observe any hernia recurrences with non-absorbable mesh 
but all ventral hernias recurred within 10 weeks of repair with absorbable implant.
155
  There 
is currently no evidence to support their use in abdominal wall reconstruction.   
 
 
1.10.3 Biological meshes 
The problems encountered with synthetic implants led to the use of biomaterials which were 
first introduced in the 1990s for soft tissue reconstruction.
156
 These products provide the 
extracellular scaffold required for tissue reconstruction by promoting angiogenesis and 
proliferation of fibroblasts and myocytes resulting in deposition of new extracellular 
matrix.
156
 Biological meshes can be classified as allografts (derived from human tissue) and 
xenografts (usually derived from porcine or bovine tissue).
157
 Tissues commonly used 
include dermis, intestinal submucosa and pericardium which undergo complete de-
cellularisation to produce a three dimensional collagen structure which is biocompatible and 
acts as scaffold for host cell population, vascularisation and tissue remodelling.
157 158
 
However, premature collagenase degradation, especially in infected or contaminated fields 
due to increase enzymatic activity, may lead to implant resorption before adequate tissue re-
growth has taken place. This may be the reason that the herniation rates associated with 
these materials are comparable to that of absorbable synthetic grafts.
155 159-161
 Supplemental 
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chemical cross-linking (with gluteraldehyde, hexamethylene diisocyanate[HDMI], etc) has 
been used since 1975 to improve biological mesh stability and resistance to enzymatic 
breakdown with the theoretical disadvantage of decreased host-tissue integration.
160 162 163
 
The different cross-linking agents produce different cross-linking structures with variation in 
the mechanical strength and performance of the collagen matrix.
156
 Table 1.6 summarises 
some of the most commonly used and available biological meshes available for parastomal 
hernia repair. 
131 164-168
 
The number of studies in the literature investigating the use of biological implants for the 
treatment of parastomal herniation has increased over the last few years but the quality 
remains modest, at best, with almost all studies being level IV.
158
 In a systematic review of 
the literature designed to assess the use of collagen-based implants for the repair of 
parastomal hernias, Slater et al showed that the overall recurrence rate was 16% after a 
median follow up of approximately 1 year. In addition, the rate of wound-related 
complications was 26.2% with no graft infections or explantations.
158
 These results are 
comparable to those achieved using synthetic meshes. It has been suggested that the great 
attraction of “biological scaffolds”  is that they can be used in infected or potentially-
infected surgical fields with explantation unnecessary for the resolution of infection.
169 170
 
The infection and explantation rates though associated with the use of synthetic meshes for 
the treatment or prevention of parastomal herniation are low.
133
 Consequently, the high cost 
of the biological implants (Table 1.6) coupled with the potential to  lose their mechanical 
strength (e.g.  Surgisis, non cross linked products) and the inability to demonstrate any 
advantages over synthetic meshes cast significant doubts on their routine use for the 
treatment or prevention of parastomal herniation.   
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Table 1.6  Most commonly available biological meshes 
 
Mesh 
 
Type 
 
Manufacturer 
 
Cross-linked 
 
Cost/ cm
2
 ($) 
 
AlloDerm 
 
Human dermis 
 
LifeCell 
 
No 
 
35.31 
 
Strattice 
 
Porcine dermis 
 
LifeCell 
 
No 
 
26.00 
 
Permacol 
 
Porcine dermis 
 
Covidien 
 
Yes 
 
18.97 
 
Surgisis 
 
Porcine intestine 
 
Cook 
 
No 
 
20.00 
 
Veritas 
 
Bovine Pericardium 
 
Synovis 
 
No 
 
22.02 
 
Tutopatch 
 
Bovine Pericardium 
 
Tutogen 
 
No 
 
- 
 
Periguard 
 
Bovine Pericardium 
 
Synovis 
 
Yes 
 
3.91 
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1.11 Conclusion 
Parastomal hernation is an important but unappreciated health care issue with significant 
negative impact on patients’ lives. Its treatment can be very challenging so avoidance of this 
complication is desirable. Prevention of herniation by prophylactic mesh reinforcement is a 
novel approach and, despite more studies required to draw defitive conclusions, it appears to 
be safe and should be offered to all patients undergoing routine stoma formation, especially 
if they are at high risk. Further  research, however, is required to address the 
aetiopathogenesis of parastomal hernia formation as until we have fully understood the 
mechanism of its formation, direct prevention and treatment will always be unsatisfactory. 
Future studies for the prevention of parastomal herniation will need to explore the use of 
biological/synthetic mesh using a standardised technique that is easy to use in both open and 
laparoscopic surgery. The study should have in the follow-up assessment radiological 
evaluation (e.g. CT ± valsava manoeuvre) of the stoma site to allow measurement of the true 
incidence of herniation and objective evaluation of any preventive interventions. The 
duration of follow up should be at least five years as it has been demonstrated that 80% of 
parastomal hernias appear within this time frame.
72
  
 
 
1.12 Aims and objectives of this thesis 
The main aims of this thesis are:  
1. To establish the true incidence of parastomal herniation in patients with permanent 
stomas and its impact on quality of life (QoL) and health care resources. 
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2. To correlate parastomal herniation with trephine size as this might facilitate the 
development of appropriate size stapling devices that control the trephine size and 
reduce the incidence of herniation.  
3. To establish the safety, reproducibility and efficacy of a novel surgical technique in 
reducing the incidence of parastomal herniation compared to standard stoma 
formation.   
4. To explore, using biochemical and radiological means, the contribution of the rectus 
abdominis muscle to the development of parastomal herniation by assessing its 
ability to repair after surgery.  
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                                CHAPTER 2  
 
         Correlation of the radiological incidence of parastomal       
       herniation with the diameter of the abdominal wall defect.  
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2.1 Introduction 
Parastomal herniation is the most common complication of permanent stoma formation. The 
precise incidence is unclear but rates between 5% and 80% have been reported in the 
literature reflecting the different forms of assessment utilised at varying follow-up 
intervals.
27 72
  Radiological evaluation of the stoma site with computed tomography (CT) has 
been used as an aid to improve the diagnostic accuracy.
171
  In a small study (n=23), CT 
detected the rate of parastomal herniation to be 78% whereas the clinical herniation rate was 
only 52%.
78
 In another prospective series of 27 patients the CT-detected rate of parastomal 
herniation was marginally higher compared to the clinical rate (44.4% versus 40.7% 
respectively) after a median follow up of 29 months.
132
 Thus, CT evaluation of the stoma 
site appears to be superior to clinical examination alone for the detection of parastomal 
herniation.  
The multifactorial aetiology of parastomal herniation is well documented (section 1.3) but 
only increasing age and abdominal wall defect size have been found to be independent 
predictors of its development on multivariate analysis.
31
 There is, however, a lack of data 
regarding the ideal trephine size with only one clinical study reporting higher rates of para-
colostomy herniation with an abdominal wall defect diameter greater than 35mm.
31
 Due to 
the lack of evidence, the majority of colorectal surgeons still continue to create a manual 
trephine large enough to accommodate the exteriorised bowel segment. The average glove 
size of general surgeons is 7.5 which equates to the creation of an abdominal wall defect at 
least 3.5cm in diameter.
39
 Consequently, the most common surgical technique is not 
“custom-fit” to the bowel size and is associated with the risk of creating an oversized defect, 
which may contribute in itself to the development of herniation.  
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The precise dimensions of the trephine were first considered to be an important factor by 
Resnick who used a circular stapling device of various diameters (17, 25 and 32mm) to 
create a trephine with only one case of herniation in 32 patients after 7 years.
40 41
 Other 
investigators have used standard circular stapling devices to construct colostomies without 
any increase in stoma related morbidity.
42 43
  
The aim of this study was to assess the radiological incidence of parastomal herniation in 
patients who had a permanent end-colostomy for malignancy and to correlate it with the size 
of the abdominal wall defect. This may allow identification of a stoma defect size that 
minimises the risk of para-colostomy herniation, provide further evidence about the 
importance of avoiding an oversized defect and contribute to the design of appropriate size 
stapling devices that facilitate trephine formation. 
 
2.2 Methods 
All patients who underwent permanent end-colostomy formation as part of a Hartmann’s 
procedure or abdomino-perineal excision of the rectum (APER) for malignancy between 
January 2004 and December 2009 at a large specialist tertiary colorectal unit (Barts’ and the 
London NHS trust) were identified from a departmental cancer registry. Patients’ 
demographics (age, gender, body mass index [BMI]), operative details (date of surgery, type 
of surgery, emergency/elective setting) and any stoma related symptoms were recorded. 
Post-operative abdominal computerised tomography (CT) scans performed for clinical 
purposes were reviewed by a single consultant radiologist for evidence of parastomal 
herniation. A parastomal hernia was defined as an incisional hernia related to the stoma 
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site.
33
 Furthermore, a parastomal hernia was classified as symptomatic if patients 
experienced faecal leakage due to poor adherence of stoma bag, pain, discomfort or 
developed complications such as bowel obstruction or incarceration secondary to the para-
colostomy hernia. 
 For patients without any radiological evidence of herniation, the latest CT scan was used to 
measure the maximum diameter of the abdominal wall defect in any direction. Patients with 
confirmed para-colostomy hernia on radiological assessment had the maximum aperture 
diameter measured using the earliest scan, in chronological order, in which a hernia could be 
identified.  
The data were analysed using a commercially available statistical analysis software 
(GraphPad Version 5, GraphPad Software Inc, La Jolla, CA). Data normality was tested 
using the De Agostino–Pearson omnibus normality test. Intergroup comparison of variables 
was performed using a Mann-Whitney U test. A p value <0.05 was considered significant. 
 
2.3 Results 
A total of 59 patients underwent an open or laparoscopic Hartmann’s procedure or APER for 
malignancy over a 5-year period. All colostomies were fashioned using a trans-peritoneal 
approach. Sixteen patients did not have any post-operative CT scans available for review and 
were excluded from the final analysis.  The study group consisted of 43 patients (22M: 21F) 
with a mean age of 69 years. (Figure 2.1) 
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There were 25 patients (58%) with radiological evidence of parastomal herniation after a 
median follow up of 26 (range 6-55) months. Eighteen patients did not have any evidence of 
para-colostomy herniation on CT assessment after 16 (range 7-49) months. The difference in 
the follow up interval of the two groups was not statistically significant (p=0.11). The two 
groups were also of similar age and although patients with parastomal hernias had a higher 
BMI (26.9 versus 23.5), it was not statistically different (p=0.24) (Table 2.1). Furthermore, 
the number of stomas formed following an emergency Hartmann’s procedure was 
comparable between the two groups. (Table 2. 1) 
 The median maximum diameter of the abdominal defect for patients with a parastomal 
hernia was 35mm (range 25-58mm).  This was found to be statistically larger (p<0.0001) 
than the median diameter of the group without herniation (22mm, range 7-36mm). Among 
patients with radiologically confirmed parastomal hernias, 11/25(44%) were symptomatic. 
The characteristics of this sub-group are shown in Table 2.2. Four patients (36%) with 
symptomatic parastomal hernias underwent surgical repair. The maximum trephine diameter 
in patients with a symptomatic parastomal hernia was 54mm (range 28-58mm) and was not 
statistically different (p=0.06) when compared to the trephine size of patients with an 
asymptomatic parastomal hernia (34mm, range 25-55mm).  
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Figure 2.1. Study flow chart 
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Table 2.1. Intergroup comparison of patient variables based on the presence of parastomal 
herniation 
 
 
Demographics 
Parastomal 
Hernia 
No parastomal 
hernia 
p-value 
Total Number 25 18 - 
Mean Age 69±14 69±12 0.89 
Female: Male Ratio 14:11 7:11 - 
BMI 
26.9 
(20.0-36.0) 
23.5 
(22.0-30.0) 
0.24 
Hartmann’s 
procedure 
 
 
13 elective 
4 emergency 
 
10  elective 
3  emergency 
 
- 
APER 7 5  
Median defect 
diameter(mm) 
35 
(25-58) 
22 
(7-36) 
 
<0.0001 
Median time of 
post-op CT(months) 
26 
(6-55) 
16 
(7-49) 
 
0.11 
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Table 2.2.   Comparison of abdominal wall defect size between symptomatic and 
asymptomatic parastomal hernia. 
 
Demographics 
Symptomatic 
parastomal hernias 
Asymptomatic 
parastomal hernias 
p-value 
Total Number 11 14 - 
Mean Age 68±12 70±12 0.76 
Female: Male Ratio 6:5 9:5 - 
BMI 
23 
(21.5-36) 
26.5 
(20.0-35.0) 
0.90 
Median defect 
Diameter (mm) 
54 
(28-58) 
34 
(25-55) 
 
0.06 
Corrective surgery 
 
4 
(36%) 
0 - 
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2.4 Discussion and conclusions 
The incidence of parastomal herniation in this study was 58% , one of the highest reported 
in the literature.
27
 Two possible reasons for this include firstly, the study group consisted of 
relatively older patients (mean age 69 years) with a diagnosis of malignancy, both of which 
are well known risk factors for herniation, and secondly, the presence of parastomal 
herniation was based on CT evaluation which is the most sensitive means of assessment. 
Forty-four percent of patients with a radiologically confirmed parastomal hernia had 
symptoms directly related to it and 36% of them required surgical repair whereas the 
majority opted to be managed conservatively or were deemed to be high risk for surgical 
intervention. Emergency surgery does not appear in this study to be associated with an 
increased risk for parastomal hernia development. This is in agreement with another  study 
evaluating transverse colostomies in 251 patients, where no difference in para-colostomy 
herniation rates was found between emergency and elective surgery.
54
 However, the 
number of patients is small so any firm conclusions will require further evaluation. 
Although patients with a parastomal hernia had statistically a larger abdominal wall defect 
when compared to patients without herniation, a distinct “cut –off” point between the two 
groups was not identified. Nevertheless, no cases of para-colostomy herniation were seen 
with an abdominal wall defect measuring below 25mm. This should be taken into 
consideration when a trephine is fashioned since a previous study reported that for every 
millimetre increase in aperture size, the risk of developing a hernia increases by 10%.
31 The 
most common technique of stoma formation, using the crude method of finger 
measurement, does not allow the creation of a precise trephine diameter.  The use of a 
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circular stapling device might be advantageous in forming a more controlled, rigid trephine 
which maintains its size and integrity with time. 
40 172
 
A limitation of this study though is its retrospective nature and relatively small study 
sample. However, most publications in this area involved small populations. More 
importantly, measurement of the size of the abdominal wall defect in the presence of 
herniation is associated with the ambiguity of whether the hernia caused the oversized 
defect or vice versa.  We attempted to reduce the influence of this factor by using the first 
scan in which a parastomal hernia was identified. In either case, neither the abdominal wall 
defect size in hernia-free patients (median 22mm), nor the fact that no herniation was 
observed with diameter below 25mm should be affected by this factor.  
In conclusion, the majority of patients who undergo end-colostomy formation for colorectal 
malignancy appear to develop a para-colostomy hernia within the first two post-operative 
years. Aperture size has been previously shown to be a potential independent predictor of 
herniation
31
 but our study suggests that creating a defect ≤25mm might reduce this risk. 
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   CHAPTER 3 
 
A case-controlled pilot study assessing the safety and efficacy of 
the Stapled Mesh StomA Reinforcement Technique (SMART) in 
reducing the incidence of parastomal herniation.  
Hotouras A, MD Thesis 2013 
 
65 
 
 
 
 
 
 
 
 
 
 
 
“The high incidence of parastomal herniation is unacceptable. All colorectal surgeons 
have a duty to prevent it”. 
 
      
Professor Norman Williams, 2010 
President, Royal College of Surgeons of England 
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3.1 Introduction 
Various technical modifications (e.g. extra-peritoneal stoma formation, stoma positioned 
lateral to the rectus abdominis muscle) have been proposed as a means of reducing the 
incidence of herniation but there is no conclusive evidence that such manoeuvres are 
effective.  Moreover, traditional stoma formation, using manual dilatation to create the 
abdominal wall defect, frequently results in an oversized aperture when a trephine ≤25mm 
is associated with reduced herniation risk.
173 
 
Three previous randomised controlled trials showed that prophylactic mesh reinforcement 
of the trephine can reduce the incidence of parastomal herniation. In two studies, a 
synthetic mesh (Vypro® or Ultrapro®) was placed as sublay (behind the rectus muscle) at 
open surgery. In the third study, a porcine collagen implant (Permacol
TM
) was implanted 
preperitoneally (between peritoneum and posterior rectus sheath) because of the fear of 
erosion. The latter was expanded into a multi-centre trial in the United Kingdom with the 
acronym “Propheci” (Prophylactic Parastomal Hernia Clinical Investigation, 
ISRCTN31730807).  Unfortunately recruitment to this trial was slow leading to its 
suspension.  Manual mesh implantation is perceived to be time consuming and 
unnecessarily cumbersome, particularly at the end of a long and challenging operation.  In 
addition, an increasing number of stomas are being constructed laparoscopically and sub-
peritoneal placement of the mesh has proved difficult by this approach.  Consequently, 
routine stoma reinforcement is not standard practice in the United Kingdom and in most 
countries worldwide.  
A simple and quick technique is therefore required for stoma formation which addresses the 
issues of aperture size and reinforcement.  The technique should also be easily reproducible 
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at both open and laparoscopic surgery.  Utilisation of a circular stapling device to create a 
controlled trephine and simultaneously reinforce it with mesh may deal with all technical 
issues and simplify the reinforcement process. 
The aim of this study was to assess the safety and efficacy of a novel surgical technique 
called SMART (Stapled Mesh stomA Reinforcement Technique) in reducing the incidence 
of parastomal herniation.   
 
3.2 Materials and Methods 
 
3.2.1 The “SMART” technique for the prevention of parastomal herniation.  
The Stapled Mesh stomA Reinforcement Technique (SMART) utilises a circular stapling 
instrument of various knife diameters (17mm, 20mm and 24mm) to create the trephine and 
simultaneously reinforce it with mesh.   
3.2.1.1 “SMART” at open surgery 
Trephine formation commences by excising a cylinder of abdominal wall skin and 
subcutaneous tissue down to the rectus sheath.  The sheath is then opened with a cruciate 
incision (Figure 3.1) and the rectus muscle is gently split in the line of its fibres (Figure 
3.2).  The anvil of an appropriate sized, purpose designed circular stapling gun 
(Compact
TM
, Chex Healthcare) is then introduced via the open abdomen.  The diameter of 
the gun depends on the diameter of the bowel which will eventually traverse the stoma 
trephine.  A purpose designed grasper is then inserted via the abdominal wall trephine to 
penetrate the posterior rectus sheath and peritoneum.  The grasper is used to grasp the anvil  
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Figure 3.1 The rectus sheath is opened by means of a cruciate incision. 
 
 
 
 
 
 
 
 
 
Figure 3.2 The rectus fibres are gently retracted to reveal the posterior rectus sheath 
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shaft of the gun and is designed not to damage it.  The grasper tip is blunted but sufficiently 
sharp to penetrate the layers it needs to transgress.  Consequently, visualisation of its tip 
when penetrating the abdominal wall is vital.  Once the anvil shaft has been grasped the 
anvil is then exteriorised through the trephine to emerge on the abdominal wall (Figure 
3.3).  Another purpose designed grasper is used externally to grasp the anvil shaft and 
steady it and facilitate its eventual mating with the spike emanating from the cartridge 
housing component of the instrument.  The collagen mesh (Permacol
TM
) which is 
configured in a circular design with a diameter of 7cm is then prepared by creating a small 
defect in its centre.  The defect in the mesh is utilised to insert the mesh onto the anvil shaft 
which is then mated with the stapler housing spike of the Compact
TM
 instrument (Figure 
3.4).  Once successful locking has been achieved the gun is closed, whilst the rectus muscle 
fibres are gently retracted, enclosing in order the mesh, the posterior rectus sheath and the 
peritoneum.  The gun is then fired and removed leaving behind a precise, rigid trephine 
with the mesh stapled in the posterior rectus sheath.   The circumference of the mesh is next 
sutured to the anterior rectus sheath with interrupted 0 PDS sutures so it lies flat against the 
anterior sheath and totally lines the trephine for 2-3cm circumferentially through the split 
muscle fibres (Figure 3.5).  The colon or ileum is then drawn through the trephine and the 
stoma is fashioned in the usual way (Figure 3.6).   
 
 
 
 
Hotouras A, MD Thesis 2013 
 
70 
 
 
Figure 3.3 The anvil of an appropriate sized COMPACT™ stapler is introduced via the 
open abdomen.  The anvil shaft is then grasped with a purpose designed instrument 
configured to prevent damage to the shaft and is then exteriorized through the trephine to 
emerge on the abdominal wall. 
 
 
 
 
 
 
 
 
Posterior rectus 
sheath/peritoneum 
Rectus muscle 
Subcutaneous fat 
Purpose designed 
grasper 
Anvil 
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Figure 3.4 The anvil shaft, with a previously prepared circular mesh of 7 cm in diameter, is 
stabilized with a purpose designed right angled grasper.  It is then mated with the trocar of 
the stapling gun.  The gun is closed, fired and withdrawn leaving a reinforced trephine (see 
Fig 3.5). 
 
 
 
 
 
Mesh  
Circular stapler 
Grasper 
Anvil 
Hotouras A, MD Thesis 2013 
 
72 
 
 
Figure 3.5 The circumference of the mesh is next sutured to the anterior rectus sheath. 
 
 
 
 
 
 
 
 
Figure 3.6 The colon or ileum is finally drawn through the trephine and the stoma is 
fashioned.  
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3.2.1.2 “SMART” at laparoscopic surgery 
With the pneumoperitoneum still maintained the abdominal wall trephine is formed down 
to the posterior rectus sheath as described above for the open technique.  If a separate 
abdominal wall incision has been created for specimen retrieval the anvil shaft can be 
inserted into the abdominal cavity and exteriorised in the same way as for the open 
technique.  If this is not the case the rectus muscle fibres can be retracted and a small 
incision made via the abdominal wall trephine in the posterior rectus sheath and 
peritoneum.  This naturally results in deflation of the abdominal cavity as the 
pneumoperitoneum is lost.  A prolene or PDS purse-string suture is next inserted into the 
edge of the incision in the peritoneum and posterior rectus sheath.  The anvil head is passed 
through this incision with the shaft exteriorised and the purse-sting is tied firmly around its 
base on the shaft.  Mating between the anvil shaft carrying the mesh and the stapler housing 
spike is then completed as described previously and the gun is closed.  Before firing, the 
pneumoperitoneum is re-created and the trephine site and position of the closed gun is 
checked to ensure no extraneous segment of bowel has been trapped between the anvil and 
the posterior abdominal wall.  After firing the gun is withdrawn and the stoma constructed 
in the usual way (please see supplementary DVD demonstrating the SMART procedure) 
 
3.2.2 Study Design 
All patients who underwent the SMART procedure in our institution from 2011 onwards 
were identified from a prospectively recorded computerised database.  Patients were 
offered the procedure on clinical grounds as being at particularly high risk for parastomal 
herniation with randomisation into a controlled trial being deemed inappropriate. All 
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patients gave informed consent and understood that this was a new variation of an 
established technique.  The study was reviewed and approved by the National Research and 
Ethics Committee (West London REC Reference Number 10/H0706/92). 
Data recorded included patient demographics (age, gender), body-mass index, American 
Society of Anaesthesiologists (ASA) grade, indication for SMART and postoperative 
complications including parastomal hernia formation. The diagnosis of herniation was 
made clinically in the outpatient department by an independent reviewer blinded to the 
procedure. In patients with stoma related symptoms (e.g. peristomal pain) computed 
tomography (CT) was used to confirm the presence or absence of herniation.  
Patients who declined SMART and opted to undergo stoma resiting to the opposite side of 
the abdomen without mesh reinforcement for symptomatic parastomal herniation during the 
same time period were used as a control group. All patients in both groups received 
prophylactic antibiotics at induction of anaesthesia. Bowel preparation and surgical drains 
around the stoma site were not routinely used.  
Statistical analyses comparing the SMART and control groups for the measurable 
parameters were performed using a commercially available software package (GraphPad 
Version 5, GraphPad Software Inc, La Jolla, CA). Data normality was assessed using the 
De Agostino-Pearson omnibus normality test. Normally distributed data are presented using 
mean and standard deviation, whereas non-normal data are presented as a median and 
range. Normally distributed data were compared using paired t-tests. Analysis of non-
normal data was performed using the Mann-Whitney U tests. A p value of <0.05 was 
considered statistically significant. 
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3.2.3 Patients and Indications 
 Twenty-two patients (16F:6M, mean age 49±16, BMI 33.0±7.0) underwent stoma 
formation with SMART (18 open: 4 laparoscopic; 11 ileostomies:11 colostomies). All 
SMART stomas were fashioned using a circular stapler with a 24mm knife diameter. 
Patients presented with either complications from a pre-existing stoma (n=15) or 
underlying conditions (n=7) such as obesity, asthma, corticosteroid use, collagen disorder 
or combination of these.  The group of patients with pre-existing stomas had either a large 
parastomal hernia unsuitable for local repair (n=6) or recurrent herniation as a result of 
previous repair (n=9) and all of them underwent resiting to the opposite site of the 
abdomen. Patients (n=7) with underlying conditions predisposing them to herniation 
underwent SMART at the index operation.  
The four patients who underwent the laparoscopic technique were all females who required 
a stoma for severe faecal incontinence (n=3) or slow transit colon (n=1).  In addition, 3 of 
them had associated recurrent full thickness rectal prolapse and 2 of them were also thought 
to have a collagen disorder and weak abdominal wall musculature.   
The control group consisted of 11 patients (6F:5M, mean age 59±15, BMI 29.0±3.0) with 
statistically similar age and body-mass index to the SMART group (Table 3.1). All control 
group patients underwent stoma resiting with no reinforcement (4 ileostomies:7 
colostomies) to the opposite site of the abdomen for symptomatic parastomal herniation.  
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Table 3.1 Demographics, physiological parameters and surgical outcome for the SMART 
and control groups.  
Variables SMART group 
n=22 
Control Group 
n=11 
p-value 
Age 49±16 59±15 0.1 
Gender ratio (F:M) 16:6 6:5 - 
ASA grade 
I 
II 
III 
IV 
 
2 
8 
12 
0 
 
0 
3 
8 
0 
 
 
- 
 
BMI (Kg/m
2
) 
 
33.0±7.0 
 
29.0±3.0 
 
0.1 
Stoma Type 
Ileostomy (%) 
Colostomy (%) 
 
11(50) 
11(50) 
 
4(36) 
7(64) 
 
0.48 
0.48 
          Risk factor 
      Parastomal Hernia 
       Other (e.g obesity) 
 
n=15 
n=7 
 
n=11 
n=0 
 
- 
Approach 
Laparoscopic 
Open 
 
4 
18 
 
0 
11 
 
- 
Recurrence Rate 4 (18%)  8(73%) 0.003 
Follow-up (months) 18 (10-24)  9 (4-25) 0.04 
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3.3 Results   
There were no intra-operative complications or immediate stoma related post-operative 
complications in either group.  In the SMART group, there was one death on the 12
th
 post-
operative day from respiratory sepsis in a patient with significant co-morbidities including 
advanced multiple sclerosis.  Two further patients, both in the SMART group, were re-
admitted within 30 days: one had radiological drainage of a pelvic collection and the 
second underwent band adhesiolysis (40 cm proximal to the stoma) for small bowel 
obstruction.  Both patients recovered uneventfully.  
The majority of patients in the control group (8/11, 73%) developed a parastomal hernia 
within the first postoperative year (9 months; range, 4-25). At a median follow–up of 21 
months (range 12-24), 3/22 (14%) SMART patients reported parastomal symptoms.  CT 
evaluation confirmed recurrent herniation in all of them, one of which required reoperation.  
It should be noted that the recurrences occurred in a patient that required cardiopulmonary 
resuscitation for myocardial infarction following hospital discharge, in a patient that 
required radiological drainage of pelvic collection twice and in a patient with a diagnosis of 
Ehlers-Danlos syndrome and significant colonic dysmotility.  A further patient without any 
stoma related symptoms was diagnosed with herniation on clinical examination, resulting 
in an overall recurrence rate of 18% (4/22)  significantly lower than that in the control 
group (p=0.003) but with longer follow-up (Table 3.1). The other 18 SMART patients were 
asymptomatic without any clinical evidence of parastomal herniation or any other stoma 
complication during the follow up period.    
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3.4 Discussion and conclusions 
 This pilot study has demonstrated that SMART is safe and reproducible and appears to 
reduce the incidence of parastomal herniation in a high risk group of patients. It should be 
emphasised that although the two groups were comparable in terms of age, body-mass 
index and stoma type, SMART patients were thought to be at significantly higher risk for 
herniation than those in the control group because some of them had a recurrence of a 
previously repaired parastomal hernia and/or a combination of conditions (e.g. collagen 
disorder, asthma) predisposing to herniation. Furthermore, they were followed up for 
almost two years whereas all control patients who developed a parastomal hernia did so 
during the first postoperative year. The high herniation rate seen in the control group is 
similar to that reported by other studies providing further evidence that stoma resiting 
without reinforcement should not be performed for such patients as recurrence is almost 
inevitable.
174
 
Stoma trephine formation using a circular stapling instrument was first described by 
Resnick at open surgery.
40
 The present technique differs in several important aspects.  It 
combines the concepts of stapling trephine creation with mesh reinforcement which has 
been shown to significantly reduce parastomal hernia rates.  It allows construction of the 
stoma trephine to be created at open and laparoscopic surgery and simplifies the 
reinforcement process.  A circular stapling instrument which is shorter than conventional 
instruments and more easily manoeuvrable with a longer trocar shaft facilitates the 
procedure, particularly in obese patients with a thick abdominal wall.  
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The reasons for the apparent efficacy of SMART to prevent parastomal herniation in this 
study warrant further discussion. The conventional technique for stoma formation involves 
stretching of the defect through the abdominal wall to accommodate the breadths of the 
surgeons’ index and second fingers.29,174  Such uncontrolled stretching of the abdominal 
wall not only may produce an oversized defect but may also result in excessive stretching 
of the rectus muscle which is likely to weaken the trephine with subsequent widening of the 
defect over time and retraction of the anterior rectus sheath leading to hernia formation.    
SMART may minimise the herniation risk by  (i) controlling the size of the defect (all 
stomas fashioned with a circular stapler with 24mm knife diameter) (ii) reinforcing the 
abdominal wall with mesh and (iii) minimising excessive stretching of the rectus muscle.   
It should be emphasised that SMART was used only in patients who were at high risk for 
herniation and for whom randomisation was deemed inappropriate in view of the findings 
from previous mesh reinforcement trials. 
72, 131, 132
 The predisposition of patients in this 
study towards herniation is, perhaps, the main reason accounting for the 18% recurrence 
rate in just under 2 years although this is significantly lower than the herniation rate (73%) 
in the control group.   
Limitations of this prospective study include its non-randomisation, the heterogeneity of 
the SMART cohort and the lack of longer term follow-up (>5 years). Nevertheless, it 
provides important data that SMART is safe and reproducible and has the potential to 
replace the current surgical technique for stoma formation since it addresses many technical 
deficiencies associated with the latter.  A change in surgical practice, however, will require 
definitive evidence from an adequately powered multicentre randomised controlled trials 
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assessing the efficacy and cost-effectiveness of SMART in patients undergoing routine 
stoma construction during open or laparoscopic surgery (please see Chapter 4).    
             
             
      
       
 
 
 
 
 
 
 
 
  
 
 
Hotouras A, MD Thesis 2013 
 
81 
 
 
 
 
          
           CHAPTER 4 
 A randomised controlled trial of Stapled Mesh stoma 
Reinforcement Technique (‘SMART’) versus standard 
technique to assess effect on parastomal herniation.   
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4.1 Introduction 
 
The high incidence of parastomal herniation and the generally unsatisfactory outcomes 
associated with its open or laparoscopic repair (Chapter 1, Section 1.8) necessitate a 
different approach with the emphasis on prevention. As discussed in Chapter 1 (Section 
1.9), Level 1 evidence suggests that insertion of a prophylactic mesh at the primary 
operation is safe and reduces the herniation rate.
72 131 132
 There is a need, however, for 
further large randomised controlled trials in all patients undergoing routine permanent 
stoma formation. Previous studies were either underpowered or inappropriately excluded 
patients at higher risk for herniation (e.g. overweight, steroid users). Furthermore, 
standardising and simplifying the technique of stoma formation and reinforcement is 
another important factor that needs to be addressed in order to improve acceptability and 
adoption of the mesh reinforcement procedure which is still not routine practice in the 
United Kingdom or abroad, partly due to the difficulty associated with laparoscopic  mesh 
implantation and the additional operative time required to do so.  
A pilot study of the Stapled Mesh stomA Reinforcement Technique (‘SMART’) has 
demonstrated  it  be safe and reproducible in a group of patients who underwent stoma 
resiting, predominantly for recurrent symptomatic parastomal herniation (Chapter 3). 
Nevertheless, SMART needs to be tested in a multicentre randomised controlled trial in all 
patients who undergo permanent stoma formation for benign or malignant disease. In the 
pilot study, SMART was performed using Permacol
®
 mesh (i.e. a cross-linked collagen 
implant) because of the fear of bowel erosion with synthetic meshes and the perceived 
merits of biological materials which provide a collagen scaffold for tissue repair and 
regeneration in potentially contaminated surgical fields (Chapter 1, section 1.10.3).  In view 
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of the lack of evidence regarding the superiority of biological meshes over synthetic ones 
and the significantly higher cost of the former, it can be argued that implantation of a 
synthetic mesh might be of similar efficacy while preventing the cost of the procedure 
spiralling to unacceptably high levels, especially in the current climate of limited healthcare 
resources worldwide. 
157 158
 
The primary aim of this study was to assess the efficacy of SMART in reducing the clinical 
herniation rate compared to the standard technique following permanent stoma formation. 
Secondary objectives included: (i) to compare the radiological incidence of herniation 
between the two techniques and correlate it  with the clinical findings,  (ii) to measure 
differences in complications associated with the two techniques, (iii) to assess the ease of 
the SMART technique compared with the standard technique and, (iv) to compare the 
quality of life between patients who underwent SMART and standard stoma formation.  
 
 
4.2 Materials and Methods 
The study was approved by the National Research and Ethics Committee in the United 
Kingdom (NREC, West London REC 3, 10/H0706/92) and by local Research and 
Development departments at participating sites. The sponsor was Queen Mary University 
of London.  
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4.2.1 Inclusion and Exclusion criteria 
All patients requiring a permanent colostomy or ileostomy for benign or malignant bowel 
disease, as part of an elective open or laparoscopic procedure, were prospectively invited to 
participate in the study. Patients were over 18 years old, gave fully informed written 
consent and agreed to the randomisation procedure. Females of childbearing potential were 
also required to provide a negative pregnancy test.   
Patients were excluded from the study for one or more of the following reasons:  
(i) Taking part in another clinical study directly relating to this one.  
(ii) Having a history of parastomal herniation. Such patients were deemed inappropriate 
for randomisation and were offered alternative surgical options with reinforcement 
(e.g. SMART, stoma resiting).  
(iii) Suffering from an untreated metabolic or systemic illness (e.g. diabetes or 
rheumatoid arthritis or any immunological disease). 
(iv) Diagnosed with a mentally limiting condition such as Alzheimer’s.  
(v) Having MRSA or clostridium difficile infection. 
(vi) Having abdominal wall sepsis 
(vii) Pregnancy 
 
4.2.2 Randomisation 
All patients who satisfied the inclusion/exclusion criteria and gave informed consent were 
enrolled into the study. Randomisation was performed on the day of surgery, following 
induction of anaesthesia, by means of opening consecutively numbered sealed envelopes, to 
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receiving either a standard stoma without reinforcement or a ‘SMART’ stoma. Patients 
were blinded as to which arm of the trial they had been entered. Un-blinding was only 
performed in case of complications, if necessary.  
 
4.2.3 Surgical technique 
 
4.2.3.1  Established technique 
The ileostomy or colostomy was formed using the surgeon’s index and middle finger to 
create a defect in the posterior rectus sheath which was then stretched, as required, to allow 
safe exteriorisation of the bowel segment.  
 
4.2.3.2 The Stapled Mesh stomA Reinforcement Technique (‘SMART’) 
The ‘SMART’ procedure for open and laparoscopic surgery has been described in detail 
previously (Chapter 3, Section 3.2). All such procedures were performed using the same 
circular stapling device (COMPACT 
TM
, CHEX HEALTHCARE). The mesh used was Vypro II
®
 
(ETHICON products worldwide, a Johnson and Johnson company) measuring 15x15 cm, 
made from approximately equal parts of absorbable polyglactin multifilament thread and 
non-absorbable polypropylene multifilament thread. After absorption of the polyglactin 
component only the polypropylene component of the mesh remains. The Vypro II
®
 mesh 
was chosen because of its relatively reasonable cost, general availability but also safety and 
efficacy in reducing parastomal herniation as shown in a previous study with five year 
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follow-up.
72
 The diameter of the mesh implanted was initially 7cm but is was subsequently 
increased to 12 cm to allow reinforcement of greater peristomal surface area.   
 
4.2.4 Power and sample size calculation  
Power is the probability of correctly rejecting a false null hypothesis.   Using a 2-group test 
of equal proportions, sample size estimation for the study was based upon a 1-sided, 5% 
significance level (alpha) and an 80% power. According to the literature on the prevalence 
of parastomal hernias, the clinical herniation rate in the control group was assumed to be 
40% at year 1 with the rate in the SMART group being 15%.  For the statistical power to be 
80%, 58 patients per each treatment arm were required. It was therefore intended to recruit 
116 patients undergoing permanent stoma formation allowing for an approximate 15% loss 
due to dropouts (e.g. death, loss of follow up). 
 
4.2.5 Data collection 
Preoperative data collection included demographics (age, sex, body mass index), relevant 
medical and surgical history (e.g. respiratory/connective tissue disorder, use of steroids, 
diagnosis of diabetes mellitus, smoking status), pre-operative albumin, American Society of 
Anaesthesiologists (ASA) grade, and indication for surgery. Preoperative quality of life was 
assess using a validate questionnaire, EQ-5D (Appendix 1).  
 Intra-operative date collection included surgical approach (open or laparoscopic), type of 
stoma (standard or SMART, ileostomy or colostomy), diameter of circular stapler used and 
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time taken for stoma formation. The ease of the technique was assessed by the operating 
surgeon using a liner analogue scale (1=difficult to 5=easy). 
Post-operative data collection included duration of post-operative stay, time taken for stoma 
to work, general complications (e.g. ileus, wound infection, chest infection), and stoma 
related complications (parastomal hernia, haemorrhage, prolapse, retraction, obstruction, 
stenosis). Post-operative quality of life was also assessed using the EQ-5D questionnaire.   
 
4.2.6 Assessment of primary end point 
Patients had their ostomies examined by clinicians blinded to the surgical procedure 
performed. The primary end point was the development of parastomal herniation on clinical 
examination at 12 months postoperatively. Computerised tomography scans were also 
performed at 12 months to identify possible subclinical herniation and to correlate the 
clinical and radiological findings and obtain objective evidence on the efficacy of the 
‘SMART’ procedure.  
 
4.2.7 Statistical analysis 
All statistical analyses were performed using a commercially available software package 
(GraphPad Version 5, GraphPad Software Inc, La Jolla, CA). Data normality was assessed 
using the De Agostino-Pearson omnibus normality test. Normally distributed data have 
been presented using mean and standard deviation, whereas non-normal data have been 
presented as a median and range. Normally distributed data were compared using paired t-
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tests. Analysis of non-normal data was performed using the Mann-Whitney U tests. A p 
value of <0.05 was considered statistically significant 
 
4.3 Results  
4.3.1 Patients Demographics 
At the time of completing this thesis, 50 of the 116 patients required, according to the 
power calculation, were recruited to the study but only 40 of them had completed their 12 
month postoperative assessment and were included in this analysis. The study flow chart is 
shown in Figure 4.1.   
Twenty patients underwent SMART (n=16 open and n=4 laparoscopically) and 20 had 
standard stoma formation (n=16 open and n=4 laparoscopically). One patient (ASA grade 3 
with diagnosis of malignancy) in the SMART group (5.0%) died within the first 
postoperative year because of disease progression. In the control arm, one patient (5.0%) 
who underwent an abdomino-perineal excision of the rectum for malignancy died within 
the first 30 postoperative days because of respiratory sepsis. They were both excluded from 
the final  analysis.  The demographic characteristics of the remaining patients that were 
followed up according to the study protocol are shown in Table 4.1. Patients in the two 
arms were of similar age (65±11 vs. 71±13 years, p=0.27), body mass index (27±6 vs. 26±9 
kg/cm
2
, p=0.62) and nutritional status (preoperative albumin 39±8 vs. 39±9 g/dl, p=1.0).  
Stomas were predominantly fashioned for malignancy (84.2 % in the control arm and 
68.4% in the SMART arm).  
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4.3.2 General complications 
In the control group, 2 patients (10.5%) had superficial infection of the laparotomy wound 
that was treated successfully with antibiotics. A further two patients (10.5%) had an intra-
abdominal collection that required radiological drainage.  Finally, another two patients 
(10.5%, one with intra-abdominal collection), developed a postoperative chest infection 
that was treated with antibiotics. Two patients in total (10.5%) developed postoperative 
ileus that resolved spontaneously.  
In the ‘SMART’ group,  two patients (10.5%) were diagnosed with post-operative ileus 
with resolved after 6 and 9 days respectively and another patient (5.3%) developed a post-
operative chest infection that was treated with antibiotics. A further patient (5.3%) 
developed perineal wound infection and dehiscence following an abdomino-perineal 
excision of the rectum and was treated successfully with antibiotics and VAC therapy. A 
final patient (5.3%) had pelvic bleeding following panproctolectomy for ulcerative colitis 
that required a laparotomy twice without any impact on the stoma site.  
 
4.3.3 Stoma-related morbidity.  
There were no stoma related complications such as stenosis, prolapse, or retraction in the 
control arm. One patient (5.3%), however, developed peristomal infection with was treated 
successfully with a course of antibiotics.  
In the SMART group, the stoma-related complication rate was also 5.3%.  This was due to 
one patient diagnosed with necrosis of the distal 2-3cm of the exteriorised bowel segment 
in the first 24 post-operative hours and required resection of the necrotic segment without 
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the need for a laparotomy. He made an uneventful recovery and he did not have a 
parastomal hernia at 12 months. There were no other complications such as infection or 
fistulation in the ‘SMART’ arm and no mesh had to be removed.  
 
4.3.4 Parastomal herniation rates 
The clinical herniation rate in the control group at 12 months was 36.8% (7 of 19 patients) 
and all hernias were confirmed radiologically. There were no subclinical parastomal hernias 
detected on CT evaluation. None of the parastomal hernias in the control group were 
symptomatic or required surgery. Four patients (21.0 %) had a clinical recurrence in the 
‘SMART’ group with an additional patient diagnosed with a subclinical parastomal hernia 
on CT yielding a radiological herniation rate of 26.3%. The reduction in the clinical 
(p=0.02) and radiological herniation rate (p<0.05) was statistically significant. It should be 
emphasised that all cases of clinical herniation in SMART group occurred with mesh 
diameter of 7cm. Following implantation of a mesh 12cm in diameter there was only one 
subclinical case of herniation among 6 patients (16.7%) which was diagnosed on CT. At the 
one year follow-up none of the recurrent parastomal hernias in the SMART group required 
re-operation.  
 
4.3.5 Technique Evaluation 
Surgeons graded standard stoma formation with 4 and above on the linear analogue scale in 
18 cases (94.7%) with only one procedure (5.3%) given a grade 2. In the test arm, 
‘SMART’ was graded with 4 and above in 42.1% of cases (n=8). It was thought to be of 
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average difficulty (grade 3) in 5 cases (26.3%), while it was found to be difficult to perform 
(grade 1 and 2) in 5 cases (26.3%).  
The mean time taken to perform a stoma was statistically similar between the two treatment 
arms (‘SMART’=22±8 min, ‘Standard’=22±9 min, p=0.91). 
 
4.3.6 Quality of Life measures 
Patients who underwent standard stoma formation had a mean preoperative score 76±9 on 
the EQ-5D questionnaire which was statistically unchanged at the 12-month assessment 
(68±9, p>0.05). The mean preoperative score for ‘SMART’ patients was 53±20 and 
improved to 65±8 (p<0.05) after 12 months.  
Mobility was unaffected in the control group with 60% reporting no problems pre- and and 
post operatively. In the SMART group, the percentage of patients reporting increased 
mobility increased from 40% to 55% (p>0.05) at the 12 month assessment point. 
In the self-care domain of the questionnaire, 100% of patients in the control group reported 
no problems but at the follow-up point only 80% (p=0.04) reported no problems. In the 
SMART group, 70% of patients had no issues preoperatively with hygiene and this 
proportion remained appeared unchanged (75% p=0.08).  A decrease in the percentage of 
patients reporting no problems with usual activities , pain and anxiety was seen in both the 
control and SMART arms of the study but the reduction was smaller in the SMART group, 
albeit not statistically significant (p=0.2).  
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Figure 4.1 Study flow chart of the SMART randomised controlled trial. 
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Table 4.1 Characteristics of patients with 12 month follow-up assessment completed 
Parameter 
SMART 
Patients 
n=19 
Standard stoma 
Patients 
n=19 
 
p-value 
Age 65±11 71±13 0.27 
Gender 6M:13F 11M: 8F - 
BMI 27±6 26±9 0.62 
Preoperative albumin 39±8 39±7 1.0 
ASA grade 
I 
II 
III 
IV 
 
2 
8 
9 
0 
 
3 
9 
6 
1 
 
 
- 
Indication for operation 
Malignancy 
Functional 
IBD 
Diverticular Disease 
Pouch Failure 
 
13 
5 
1 
0 
0 
 
16 
0 
1 
1 
1 
- 
Type of stoma 
Colostomy 
Ileostomy 
 
15 
4 
 
16 
3 
 
 
- 
Time taken for stoma 
(mins) 
22±8 22±9                     0.91 
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4.4 Discussion and conclusions                          
In this randomised controlled trial, preliminary results suggest that SMART reduces the 
incidence of parastomal herniation within the first postoperative year in patients who have 
undergone permanent stoma formation. The parastomal herniation rate following SMART 
is comparable to the rates reported previously following prophylactic mesh reinforcement 
of the stoma site (Chapter 1, Table 1.5) but direct comparison is not possible because of the 
different methodologies, selection criteria and mode of assessment. It should be 
emphasised, however, that patients were not excluded from this study if they were at high 
risk for herniation (e.g. obesity, respiratory disorders) and their mode of assessment 
included both clinical and radiological means in contrast to previous studies.
72 132
  
The reduction in the herniation rate appears to be associated with improvements in quality 
of life on certain domains (e.g. mobility, overall score) of the EQ-5D questionnaire 
although it is difficult to attribute them exclusively to the reduced incidence of herniation 
because of the different pre-operative scores of patients in the control and test arms of the 
study.  
Stoma-related morbidity did not differ between the treatment arms. One case of stoma 
necrosis occurred in the SMART group but it is likely to be related to the blood supply of 
the distal bowel segment being under tension rather than compression of the mesentery by 
the stapled trephine since the complication did not persist following resection of the 
affected segment.  Additionally, there were no reported cases of mesh infection, fistulation 
or explantation in the SMART cohort during the observation period, providing further 
evidence that prophylactic mesh reinforcement is safe and should be routinely offered to all 
patients who undergo permanent stoma formation. This study has also contributed to 
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existing evidence that synthetic meshes such as Vypro
®
 are safe and can be used to prevent 
parastomal herniation in preference to biological materials in view of their significantly 
lower cost.
158
  
SMART did not appear to prolong the operating time and although technically more 
difficult than standard stoma formation, it was still graded as average or less than average 
difficulty in approximately two-thirds of cases. This figure may improve in the future as 
surgeons perform a greater number of SMART stomas and become more familiar with its 
technical aspects. Furthermore, the technique may be further simplified by gluing or 
stapling rather than suturing the mesh in the anterior rectus sheath with potential reduction 
in its actual operative time and greater surgeon acceptance. It can also be argued that, in 
view of its efficacy and ease of use in open or  laparoscopic surgery, the procedure may 
become the “gold standard” for stoma formation.  
It is believed that the superior efficacy of SMART in reducing the rate of parastomal 
herniation is due to the fact that it avoids creating an oversized defect, an independent risk 
factor for herniation, and simultaneously reinforces the abdominal wall, especially the 
stronger anterior rectus sheath, with mesh. All stomas were fashioned using circular 
staplers with knife diameters less than 25mm which results in the creation of a controlled, 
rigid, reinforced trephine that withholds its size and integrity with time. Nevertheless, the 
procedure carries the additional cost of £400 pounds per patient which is attributed to the 
use of the stapling device (£300) and the mesh (£100). This has to be interpreted in the 
context of a reduction in the incidence of parastomal herniation and avoidance of an open 
or laparoscopic operation for a symptomatic parastomal hernia which carries a much higher 
cost and the potential for morbidity (Chapter 1, section1.8).
174
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The encouraging results associated with SMART should be interpreted in the context of 
two important limitations. Firstly, the study was designed to recruit 116 patients and this 
preliminary analysis is based on 40 patients who completed their year one postoperative 
assessment. Thus, definitive conclusions require completion of recruitment and statistical 
validation. Secondly, all recruited patients will need to be followed up for at least 5 years to 
assess the long-term rates of infection, parastomal herniation and fistula formation in order 
to establish the true safety and efficacy of SMART and whether it should be routinely 
performed in all patients undergoing permanent stoma formation.  
In conclusion, the ‘SMART’ technique refines and standardises stoma formation and 
reinforcement and addresses many technical limitations associated with manual stoma 
formation which may explain its current superiority in preventing parastomal herniation. 
Further long-term data of this RCT, however, will be needed to determine its true efficacy.   
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                            CHAPTER 5 
An explorative study into the use of mechano-growth 
factor (MGF) as a biomarker for muscle injury.  
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5.1 Introduction 
It is well known that striated muscles respond to mechanical stimuli with hypertrophy and 
increase in muscle mass. Muscle growth is under the influence of the growth hormone 
(GH)/insulin-like growth factor-1(IGF-1) axis. GH is produced by the pituitary and induces 
IGF-1 expression in the liver which is then released into the circulation, regulating systemic 
growth and development.
175 176
 However, mechanical stimulation of a particular muscle 
induces localised hypertrophy implying that there must be autocrine factors controlling 
growth and muscle phenotype. Animal experiments have shown that rapid hypertrophy of 
the tibialis anterior due to mechanical stimulation
177
 is accompanied by a huge increase in 
mRNA indicating that muscle fibre hypertrophy may be controlled at the level of 
transcription with the increase in  mRNA suggesting that more message is translated into 
protein.
178
 Conversion of this mRNA product to cDNA and subsequent sequence analysis 
demonstrated it to be a splice variant of the IGF-1 gene but with a different sequence to the 
hepatic or systemic IGF-1 isoform (IGF-1Ea).
179
 As this splice variant was expressed only 
in mechanically stimulated but not resting muscles it was termed mechano-growth factor 
(MGF).
180
  
In vivo experiments have shown that intramuscular administration of the cDNA of both 
IGF-1Ea and MGF resulted in a 25% increase in muscle fibre size within 3 weeks.
175
 
However, injection of a viral construct containing the hepatic IGF-1 isoform (IGF-1Ea) 
produced a 15% increase in muscle mass in over four months.
181
 The explanation for the 
rapid muscle hypertrophy following MGF administration is that the two isoforms are both 
important regulators of muscle mass but perform different functions. In vitro experiments 
involving muscle stem cell cultures treated with mature IGF-1 increased in mass and fused 
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to form myotubes. In contrast, treatment of muscle stem cultures with MGF increased the 
number of myoblasts which did not fuse but maintained their integrity as mononucleated 
cells.
182
 It is now clear that MGF activates muscle stem cells which provide the extra nuclei 
for growth (i.e. muscle is a post mitotic tissue) and “kick starts” the hypertrophy process 
whereas the IGF-1Ea isoform is responsible for up-regulating protein synthesis. 
175
  Further 
evidence confirming the different roles of the two isoforms, MGF and IGF-1Ea, is provided 
by the distinctly different expression kinetics. Exercise and muscle damage induce initial 
splicing of the IGF-1 gene towards MGF but after a day the gene is almost completely 
spliced towards the IGF-1Ea isoform which then drives the anabolic process.
183 184
  
The ability of muscles to respond to exercise and injury is age-dependent. Animal 
experiments showed that older muscles are more susceptible to injury and regenerate more 
slowly resulting in impaired functional recovery.
185
  Muscle regeneration is dependent on 
the pool of stem cells to provide the extra nuclei for repair and growth but this pool is not 
adequately replenished in elderly muscles
186
 which  may be due to reduced ability to 
express MGF.
187
 In particular, mechanical overloading of animal striated muscles resulted 
in over-expression of MGF mRNA which was three to five times higher in younger 
animals. IGF-1Ea mRNA levels were also up-regulated following mechanical stimulation 
but there was no age- related effect. In a similar human study, it was established that MGF 
and IGF-1Ea mRNA resting expression levels did not differ between young (25-36 years) 
and elderly (76-82years) subjects. However, mechanical overloading of the quadriceps 
femoris muscle resulted in significant increase in MGF mRNA expression in young but not 
elderly subjects within 2.5 hours.
176
 Furthermore, mechanical overloading did not affect the 
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IGF-1Ea levels in the two groups confirming once again the differential regulation, roles 
and expression profiles of the two isoforms. 
Age has been shown to be an independent risk factor for the development of herniation 
which may be related to intra-operative muscle damage and its ability to recover 
postoperatively.
188
 This may explain why surgical techniques (i.e. lateral rectus abdominis 
positioned stomas) that preserve muscle integrity and avoid muscle fibre splitting and 
stretching reduce the incidence of para-stomal herniation even in the presence of other risk 
factors.
189
  It is thought that the ‘SMART’ procedure minimises overstretching and muscle 
damage which contributes to its higher efficacy in preventing parastomal herniation.  
Previous research has shown up-regulation of IGF 1Ea and MGF variants in the levator ani 
muscle following stretch injury after vaginal delivery. Cortes et al observed markedly up-
regulated MGF (> 100-fold) and IGF-1Ea (>1000fold) levels in women within 1 hour of 
delivery compared to the baseline levels of control subjects. They concluded that damaged 
levator ani muscle results from stretch and overload after vaginal delivery.
190
 We 
hypothesise that quantification of MGF and IGF-E1a expression of the rectus abdominis 
muscle will inform on the extent of the injury and the muscle’s reparative ability in 
response to iatrogenic injury.  This may provide the basis for novel therapeutic 
interventions including potential MGF replenishment therapy to prevent parastomal 
herniation.  The proposed study using the clinical model of parastomal hernia could then be 
extrapolated to the wider field of prevention of incisional hernias. 
The aim of this explorative study was to quantify rectus abdominis MGF and IGF-1Ea 
levels intra-operatively and assess the potential use of MGF as a biomarker for quantifying 
abdominal muscle injury.  
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5.2 Materials and Method 
5.2.1 Patients  
Participants in the SMART randomised controlled trial were also recruited to this study 
following fully informed consent. Only patients scheduled to undergo permanent stoma 
formation during open surgery were recruited because of the difficulty associated with 
obtaining laparoscopic biopsies of the rectus abdominis muscle and the variable effect of 
pneumoperitoneum which stretches the abdominal musculature. Stomas were fashioned 
using either the standard technique or the SMART technique depending on the outcome of 
the randomisation process (Chapter 4, section 4.2.2). Ethical approval was obtained by the 
National Research and Ethics Committee in the United Kingdom (NREC, West London 
REC 3, 10/H0706/92).    
 
5.2.2 Power & sample size calculation 
As this was a feasibility study a power calculation was not performed.  It was decided to 
recruit a total of 10-15 consecutive patients of both genders to undergo intra-operative 
biopsy of the rectus abdominis muscle during open surgery.  
 
5.2.3 Muscle biopsy procedure 
Fully anaesthetised patients underwent random biopsy during laparotomy, using a 5mm 
punch biopsy needle (STIEFEL
®
 biopsy punch), of the right and left rectus abdominis 
muscle at the start of the operation when the muscle became visible and just before closure 
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of the midline laparotomy wound. Random biopsies were similarly obtained during stoma 
formation, whether standard or SMART, from the rectus muscle immediately after opening 
of the anterior rectus sheath and before exteriorisation of the bowel. The biopsies were 
immediately submerged in RNA later stabilisation reagent (QIAGEN, Crawley, UK) to 
prevent RNA degradation and were stored in -80
o
 C within 24 hours.  
 
5.2.4 Processing of samples 
5.2.4.1 RNA extraction and quantification 
Total RNA was extracted from the muscle samples according to the detailed protocol in 
Appendix II. The extracted RNA was dissolved in RNAse-free water and the concentration 
was determined spectrophotometrically using NanoDrop
®
 (NanoDrop Technologies Inc, 
Delaware, USA) which measures sample absorbance at 260nm and 280nm wavelengths. 
Samples were measured twice with the mean absorbance reading at 260nm wavelength 
designated as the RNA concentration. RNA preparation quality was expressed by 
representing absorbance readings as a ratio, with reading taken at 260nm wavelength 
identified as numerator and reading at 280nm wavelength designated as the denominator. 
Preparation with ratios ranging from 1.8-2.1were only used for subsequent analysis with all 
other samples discarded.  
 
5.2.4.2 cDNA synthesis using reverse transcriptase 
RNA transcription  into complimentary DNA was performed using the Omniscript reverse 
transcriptase kit (QIAGEN, Crawley, UK). To facilitate the efficiency of reverse 
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transcription in transcripts that were expressed at low levels, such as MGF, short sequence 
specific dodecamers 50 to 100 base pair downstream of the PCR reverse primers were used. 
The components required for the reverse transcription reaction and the protocol used are 
described in detail in Appendix III. 
 
5.2.4.3 Generation of RT-PCR standards 
PCR products for the MGF and IGF-1Ea genes were generated using the protocol described 
in Appendix IV. Following RT-PCR, PCR products were subject to agarose gel (2%) 
electrophoresis with a DNA ladder to confirm product size. PCR products were excised 
from the gel and purified using the QIA quick gel extraction kit (QIAGEN) according to 
the protocol in Appendix V. Based on the concentration of DNA obtained (measured using 
NanoDrop), the number of copies in a given volume was calculated and used to make serial 
dilutions of standards with known copy numbers of the gene of interest (Appendix VI).  
 
5.2.4.4. Real time polymerase chain reaction (RT-qPCR) 
In this step, complimentary DNA is amplified and quantified using multiplexed gene 
specific primers. Target specific primers for MGF and IGF-1Ea as well as three reference 
“housing-keeping” genes GAPDH, B2M (beta-2-microglobulin) and B-actin that have been 
shown previously to be stable under the chosen experimental conditions in our laboratory 
were used.  Primer sequences (Table 5.1) were exactly the same as the ones used by Cortes 
et al previously to quantify MGF and IGF-1Ea expression.
190
 All primers were synthesized 
by Sigma-Aldrich (Sigma-Aldrich Ltd, Dorset, UK).  
Hotouras A, MD Thesis 2013 
 
104 
 
 
Quantification of mRNA coding for IGF-1Ea, MGF, GAPDH, B2M and B-actin was 
performed with RotorGene 6000  (Qiagen, UK) using SYBR green I (Qiagen, UK), a dye 
that binds to the minor groove of double-stranded DNA. Quantitative PCR was performed 
in a total reaction volume of 20μl containing 300 μM forward primer, 300 μM reverse 
primer, 10 μl SYBR Green and 4ul standard/100 ng cDNA template. Reaction conditions 
were as follows: initial activation at 95 
o
C for 15 minutes, denaturation at 95 
o
C for 20 
seconds, annealing at 60 
o
C for 20 seconds, extension at 72 
o
C for 20 seconds and final 
extension at 72 
o
C for 15 seconds. Reactions were run for 30-40 cycles.  Rotor Gene 6000 
series software 1.7 was used for analysis of copy number in unknown samples. On 
completion of PCR, melt curve analysis was performed to confirm the presence of one 
single product, with all PCR products sequenced to confirm identity (Figure 5.1). Test 
samples were run in duplicate in parallel with cDNA standards of known gene copy number 
and negative controls (no template and no enzyme). Cycle threshold (CT) values were used 
for analysis, and actual gene expression in test samples was quantified using the generated 
standard curve (Figure 5.2). All samples of unknown concentration fell within the dynamic 
range of the standard curve. Data for the genes coding for MGF and IGF-1Ea were then 
expressed relative to a normalisation factor generated from a panel of 3 housekeepers 
(GAPDH, β-actin and β-2 microglobulin) using a commerically available software 
(GenNorm,  Biogazelle, Version 3.5, Belgium). Runs were performed in duplicate and 
mean values were subsequently used for analysis.  
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Table 5.1 Primer sequences used in real-time PCR 
 
 
 
 
 
 
 
Primer Name     Sequence (5’ to 3’) 
     
Product       
 Size (bp)        
           
        Accession  
              no 
GAPDH 
Forward: GGAAGCTTGTCATCAATGGAA 
Reverse:  TGGACTCCACGACGTACTCA 
     102           NM_002046.3 
В-actin 
Forward: CCAACCGCGAGAAGATGA 
Reverse: CCAGAGGCGTACAGGGATAG 
      97           NM_001101.2 
B2M 
Forward: TAGGAGGGCTGGCAACTTAG 
Reverse: CTTATGCACGCTTAACTATCTTAACAA 
      127          NM_004048.2 
IGF-1Ea 
Forward: GCCTGCTCACCTTCACCAGC 
Reverse: TCAAATGTACTTCCTTCTGGGTCTTG 
     303       U40870 
IGF-1Ec (MGF) 
Forward: CGAAGTCTCAGAGAAGGAAAGG 
Reverse: ACAGGTAACTCGTGCAGAGC 
      150         X57025 
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Figure 5.1 Melting curve profile corresponding to a single band of the predicted size                
for (A) MGF and (B) IGF-1Ea.   
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Figure 5.2. (A) Amplification profile of standards of known concentrations of MGF DNA. 
(B) the standard curve generated by the Rotor Gene software. For each sample the crossing 
point was plotted against the known concentration of the standard. The resulting curve is 
shown as a graph of cycle number vs log concentration.  
          (A) 
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5.3 Data analysis 
The data were tabulated on an Excel Spreadsheet. Data normality was assessed using a 
commercially available software package (GraphPad Version 5, GraphPad Software Inc, La 
Jolla, CA). Data normality was assessed using the De Agostino-Pearson omnibus normality 
test. Normally distributed data have been presented using mean and standard deviation, 
whereas non-normal data have been presented as a median and range. Normally distributed 
data were compared using paired t-tests. Analysis of non-normal data was performed using 
the Mann-Whitney U tests. The level of statistical significance was taken as <0.05. 
5.4 Results  
There were 13 patients (6M: 7F) with a median age of 77 years (range, 40-81) who 
underwent open biopsies of the rectum abdominis muscle during laparotomy and stoma 
formation (6 SMART and 7 standard). 
 
5.4.1 MGF expression levels 
The median baseline (i.e. start of laparotomy) MGF expression level of the right rectus 
abdominis muscle was 309 (range 184-560) and did not differ statistically to the baseline 
MGF expression of the left rectus abdominis muscle (median 162, 113-7195; p=0.4). Just 
before closure of the laparotomy wound, the MGF levels of the right (median 288, range 
158-5160) and left (median 180, range 70-544) rectus abdominis muscles were again 
comparable (p=0.3). Comparison of the MGF expression levels for each muscle between 
the start and end of operation did not reveal any statistical difference (right rectus p=0.5; 
left rectus p=0.3).  No statistical difference in the expression levels was seen between men 
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and women for either the right or left rectus muscle at the start or the end of the operation. 
The effect on age on the MGF expression could not be established as all patients, but one 
(age 40), were over the age of 70.  
The median MGF level before stoma formation (as the anterior rectus sheath was opened) 
was 305 (126-3485) and did not differ to the level after stoma formation (188, 136-1045; 
p=0.3) or with the surgical technique used (SMART versus standard; p=0.6) 
 
5.4.2 IGF-1Ea expression levels 
The baseline IGF-1Ea level for the right rectus muscle was 3438 (626-11081) and was not 
different to its expression level just before closure of the laparotomy wound (median 2621, 
range 222-11524; p=0.81). Similarly, there was no difference in IGF-1Ea levels between 
start (median 1022, range 564-18298) and end of the laparotomy (median 1878, range 
187.6-15987; p=0.81) for the left rectus muscle. No difference in the expression levels was 
seen between the two muscles at the above time points (p>0.5). No statistical difference in 
the expression levels was seen between men and women for either muscle. 
The IGF-1Ea level before stoma formation (median 761, range 566-7234) was not 
statistically different to the level after stoma formation (median 791, range 500-6236; 
p=0.17) and did not differ with surgical technique (SMART versus standard, p=0.67). 
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 5.5 Discussion and conclusions 
In this pilot study, the MGF and IGF-1Ea expression levels did not appear to change intra-
operatively. Levels were similar for both men and women and were not influenced by the 
surgical technique used to fashion the abdominal stoma. IGF-E1a appeared to be expressed 
approximately ten times more than MGF which  is consistent with the results of a previous 
study.
176
 This is thought to reflect its hepatic synthesis and release into the systemic 
circulation.
190
  
The failure of this study to demonstrate any change in the intra-operative expression of 
MGF and IGF-1Ea may be due to the small sample size introducing a type II error. 
However, the pharmacokinetic profiles of the two gene products and the age of the study 
participants are two parameters that require further discussion. Using an animal model to 
study the MGF and IGF-1Ea expression kinetics in chemically and mechanically damaged 
striated muscle, Hill and Goldspink showed that MGF levels peak within one day while 
IGF-1Ea reaches its peak on day 11 when the MGF expression has progressively 
declined.
183
 The different expression profiles of the two gene products reflect their different 
function with MGF causing rapid proliferation of myotubes and IGF-1Ea enhanced 
terminal differentiation and fusion of satellite cells with the damaged muscle fibres in order 
to kick-start muscle repair and regeneration.
182
 Consequently, the  relatively short time 
period between the initial and repeat biopsy might be an  important contributing factor  
since the duration of a laparotomy for a colorectal operation is approximately 3-4 hours 
which may not be enough to allow for the increased gene expression to be detected. 
Nevertheless, Hameed et al reported increased MGF expression between 2% and 864% of 
the quadriceps femoris muscle within 2.5 hours following mechanical stimulation.  The 
Hotouras A, MD Thesis 2013 
 
111 
 
 
increase was only observed in young healthy men of approximately 30 years of age while 
older subjects (mean age of 75 years) did not demonstrate any change in the MGF 
expression. In the same study, the baseline and post- mechanical stimulation levels of IGF-
1Ea were not different between younger and older subjects.
176
 The median patient age in 
this cohort was 77 years and this may be another contributory factor explaining the lack of 
differential expression.  
Despite the negative findings of this preliminary study, the results should be taken into 
consideration when designing similar future studies exploring the use of MGF as biomarker 
for abdominal muscle injury and repair.  In particular, increasing the interval between the 
initial and repeat biopsy, in order to establish whether a prolonged time period allows for 
increased gene expression to be measured, seems appropriate. MGF expression peaks at 24 
hours with increased IGF-Ea expression thereafter but performing serial abdominal muscle 
biopsies in the early postoperative period is not possible as most patients will not return to 
the operating room, unless clinically required. Furthermore, there are valid ethical concerns 
associated with recruiting high-risk postoperative patients in an experimental study. While 
the ideal study may not be possible due to the aforementioned reasons, an alternative study 
may want to recruit patients who undergo temporary ileostomy formation for benign or 
malignant intra-abdominal pathology. In this scenario, the initial biopsy can be performed 
during ileostomy formation with the repeat biopsy at 3-6 months when the patient is 
scheduled to undergo ileostomy closure. This can also allow recruitment of younger 
patients who undergo stoma formation for inflammatory bowel disease, thus allowing the 
effect of age on MGF and IGF-E1a expression to be studied. Recruiting paediatric patients 
undergoing major abdominal surgery and stoma formation is another interesting potential 
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cohort in which peri-operative MGF should be assessed in view of the greater ability of 
younger muscles to regenerate.
185
 
In conclusion, this study has not demonstrated a role for MGF or IGF-E1a in abdominal 
muscle injury and repair. The feasibility of performing a methodologically improved study 
is in doubt because of the pharmacokinetic profiles of these gene products and the ethical 
problems associated with subjecting postoperative surgical patients into serial abdominal 
wall biopsies. An animal model should be used in the first instance in order to establish 
whether these products can be used as diagnostic and therapeutic means for incisional and 
parastomal hernias. 
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           CHAPTER 6 
                A radiological assessment of rectus abdominis  
                       muscle in parastomal herniation 
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6.1 Introduction 
The mechanism of wound separation and hernia formation is multi-factorial and involves 
chemical and mechanical pathways (please see Chapter 1, section 1.2).  Chemical 
mechanisms involve collagen synthesis and deposition with the local wound healing 
environment also being influenced by factors such as ischemia and infection.
191
 The 
abdominal wall, however, is a muscular structure under a dynamic equilibrium of forces 
which are disturbed following laparotomy and stoma formation. In particular, when a 
midline incisional hernia develops, the abdominal wall muscles express a pattern of 
changes which are characterised by atrophy.
23
  
There is currently no evidence regarding the relationship between muscle structure or size 
and parastomal hernia formation. Objectively assessing the structure or function of the 
abdominal wall may provide improved means of risk stratification and guide on different 
management strategies for patients with different physiological characteristics. It is 
standard practice for patients with colorectal malignancy to undergo computed tomography 
(CT) imaging to assess the extent of the disease and plan their surgical treatment. Routine 
cross-sectional images, however, may also inform on the abdominal muscle size and 
content and its contribution to the development of parastomal herniation. CT is a non-
invasive technique that is considered one of the criterion measures for assessing skeletal 
muscle mass.
192
 Previous studies showed that CT images taken at T12-L1 and L4-L5 inter-
vertebral axis can be used to assess skeletal muscle mass and density.
192 193
 Furthermore, in 
view of the non-invasive nature of imaging and its invariable availability prior to any major 
surgical intervention, investigators have explored its ability to assess muscle size and its 
relation to age and surgical outcomes.
194
 
195
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CT has the capability to distinguish between different tissues in vivo on the basis of their 
attenuation characteristics which are related to tissue density and composition.
196
 CT based 
attenuation values are expressed in Hounsfield units (HU) on the basis of a linear scale 
using water as the reference (0 HU). In particular, CT can distinguish adipose tissue which 
has a negative attenuation value whereas muscle attenuation is positive. The detailed spatial 
assessment of attenuation coefficients provided by CT can be used to assess tissue areas 
with a specific range of attenuation values and the mean tissue attenuation.  Previous 
studies using CT to assess muscle composition have reported an association between 
reduced skeletal muscle attenuation and diminished muscular strength.
197
 Further studies 
have also shown that weight loss increases the mean attenuation value of muscle which is 
related to its lipid content.
196 198
 
The aim of this study was to radiologically quantify the preoperative and postoperative 
structure of the rectus abdominis (RA) muscle and establish whether structural changes are 
related to the development of parastomal herniation.  
 
 
6.2 Materials and Method 
6.2.1 Radiological assessment 
Pre-operative and postoperative 5mm cross-sectional abdominal images obtained using an 
electron beam CT by standard protocol following intravenous contrast administration were 
examined. Measured variables included:  rectus abdominis (RA) cross-sectional area 
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(CSA), maximum thickness and maximum density in Hounsfield units.  All parameters  
were measured at the mid inter-vertebral horizontal axis at the T12-L1 and L2-L3 levels.  
The CSA of the right and left  RA muscle was measured by outlining its borders from the 
lateral aponeurotic attachment to the linea alba and calculating the enclosed area and  
maximum muscle density (Fig. 6.1).  Maximum muscle thickness was measured as the 
distance between the deep and superficial fascia at the widest distance of the enclosed area. 
All these steps were performed in a semi-automated fashion using algorithms programmed 
in the computer system of our Radiology department (SECTRA PACS IDS 5; version 11.4, 
2009; IMTEC AD, Sweden).  
Rectus abdominis muscle reconstruction was also performed by using all 5mm cross 
sectional images, as described previously, from the xiphisternum to the pubic symphysis. 
Total muscle volume and mean density were calculated using a commercially available 
software (OsiriX MD, Pixmeo SARL, Switzerland).  
All measurements were performed by two researchers and an average value was used for 
the final analysis. 
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Figure 6.1 Illustration of radiological assessment of rectus abdominis muscle in a  
patient who developed a large parastomal hernia.  
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6.2.2 Patients 
All patients who underwent permanent stoma formation in our institution (i.e. Barts’ Health 
NHS Trust) as part of the previously described SMART randomised controlled trial 
(Chapter 4) were included in the study. The right and left rectus muscle was assessed at 
baseline (using the preoperative CT scan) and postoperatively at one year.  The scans were 
performed according to the SMART trial protocol to detect a parastomal hernia (Chapter 4, 
section 4.2). Patients who were recruited in other centres were excluded from this study 
because their preoperative and postoperative radiological assessment was performed using 
different equipment, dose of contrast and imaging protocols. Data collected prospectively 
included patient demographics (age, gender, body-mass index [BMI]) and radiological 
evidence of parastomal herniation . 
 
6.2.3 Statistical analysis 
The data were tabulated on an Excel Spreadsheet. Data normality was assessed using a 
commercially available software package (GraphPad Version 5, GraphPad Software Inc, La 
Jolla, CA). Data normality was assessed using the De Agostino-Pearson omnibus normality 
test. Normally distributed data have been presented using mean and standard deviation, 
whereas non-normal data have been presented as a median and range. Normally distributed 
data were compared using paired t-tests. Analysis of non-normal data was performed using 
the Mann-Whitney U tests. A p value of <0.05 was considered statistically significant 
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6.3 Results  
There were 20 patients (14F: 6M) with a median age of 70 years (range 40-84) who 
underwent permanent stoma formation (colostomy n= 18 or  ileostomy n= 2) in open 
(n=18) or laparoscopic surgery (n=2). The majority of patients  were operated for colorectal 
malignancy (n=18, 90%) with the rest requiring a permanent stoma for inflammatory bowel 
disease (n=1, 5%) or a functional bowel disorder (n=1, 5%).  Preoperative and 
postoperative abdominal CT scans were available for all of them.  
 
6.3.1 Preoperative and postoperative muscle radiological assessment  
 
T12-L1 Level 
The pre-operative CSA  (median 300.3 mm
2
, range 123.3-774.4) of the rectus muscle on 
the stoma site was not different from the CSA on the non-stoma (control) side (median 
322.4 mm
2
, range 112.6-840.8; p=0.8). Postoperatively, the CSA on the stoma (199.3mm
2
, 
range 109-605.3, p=0.1) and non-stoma (258.4 mm
2
, range 140.0-563.6, p=0.1) sides 
appeared reduced  but comparable to one another [p=0.2, (Table 6.1)]. Muscle thickness on 
the stoma side was statistically reduced at the one year assessment compared to baseline 
(5.5 mm versus 6.5 mm, p=0.04) but muscle density appeared unchanged. Preoperative and 
postoperative muscle thickness and density for the non-stoma side were also statistically 
comparable (Table 6.1).  
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L2-L3 Level 
The CSA and thickness of the rectus muscle on the stoma side decreased postoperatively 
compared to baseline but the difference was not statistically significant (Table 6.1). The 
peri-stomal muscle density appeared increased but, once again the effect did not attain 
statistical significance. All three studied variables appeared unchanged for the rectus 
muscle on the non-stoma side (Table 6.1). There was no statistical difference in the 
preoperative and postoperative values of the three parameters for the stoma and non-stoma 
sides.  
 
 
Muscle reconstruction 
The preoperative muscle volume did not differ between  the stoma (91.0±44.2 cm
3
) and 
non-stoma sides (94.8±47.2cm
3
; p=0.8). Postoperatively, muscle volumes were comparable 
(p=0.1) between the stoma (89.6±36.8 cm
3
; p=0.7) and non-stoma sides (90.4±40.1cm
3
; 
p=0.4) without any change from their  baseline values (p=0.1).  
Mean preoperative muscle density was not statistically different (p=0.8) between the stoma 
(20.7±17.7 Hounsfield units) and non-stoma sides (18.7±22.4 Hounsfield units). 
Postoperative muscle density appeared reduced for both muscles  [( stoma side 16.9±17.5 
Hounsfield units; p=0.3);(non-stoma side 18.4±21.5 Hounsfield units)]  but not statistically 
different when compared to baseline values or to each other (p=0.1). 
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Table 6.1. Preoperative and postoperative radiological muscle assessment 
 
 
 
Parameter Preoperative Postoperative p-value 
 
T12-L1 Level 
   
CSA(stoma) 
 
CSA(non-stoma) 
300.3 (123.0-774.4) 
 
322.4 (112.6-840.8) 
199.3(109.7-605.3) 
 
258.4(140.0-563.6) 
0.1 
 
0.1 
Thickness(stoma) 
 
Thickness(non-stoma) 
6.5 (6.0-10.2) 
 
6.0 (5.0-11.0) 
5.5 (3.4-8.2) 
 
6.5 (3.5-10.4) 
0.04 
 
0.7 
Density (stoma) 
 
Density (non-stoma) 
47 (14-56) 
 
40  (20-67) 
45(10-62) 
 
44(14-76) 
0.8 
 
0.8 
 
L2-L3 Level 
   
CSA(stoma) 
 
CSA(non-stoma) 
327.7 (125.3-614.8) 
 
307.7 (125.5-633.4) 
264.2(136.6-520.2) 
 
349.5(153.2-543.0) 
0.3 
 
0.8 
Thickness(stoma) 
 
Thickness(non-stoma) 
6.1 (3.1-13.0) 
 
6.3 (3.0-13.0) 
5.3 (3.4-11.6) 
 
6.3 (4.0-11.6) 
0.5 
 
0.8 
Density (stoma) 
 
Density (non-stoma) 
25 (-62-54) 
 
39  (-44-55) 
47(-1-74) 
 
43(-29-70) 
0.1 
 
0.3 
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6.3.2 Preoperative and postoperative muscle radiological muscle assessment of 
patients with parastomal hernia versus patients without herniation. 
There were 7 patients (age 67±15years, BMI 27±8kg/m
2
) who were diagnosed 
radiologically with a parastomal hernia while 13 (age 63±14years, BMI 29±10kg/m
2
) did 
not have any evidence on CT assessment. Age (p=0.3) and BMI (p=0.5) were similar for 
the two groups.  
 
T12-L1 Level 
Muscle assessment at T12-L1 revealed that all measurable parameters were reduced 
postoperatively compared to baseline for patients with herniation but the differences were 
not statistically significant (Table 6.2). Patients without parastomal herniation also 
demonstrated reduced CSA and thickness compared to baseline but the effect was again not 
statistically significant (Table 6.2) Intergroup comparison revealed similar preoperative 
CSA (292.3 versus 282.0 mm
2
, p=0.9), muscle thickness (6.0 versus 6.5mm, p=0.5) and 
density (29 versus 49 Hounsfield units, p=0.5) between hernia and non-hernia patients. 
However, post-operatively muscle density was significantly reduced in patients with 
herniation compared to patients without a hernia (23 versus 53 Hounsfield units, 
p=0.04;Table 6.2). A similar effect was observed for muscle thickness with hernia patients 
having a thinner muscle on the stoma side (4.7 versus 6.0mm, p=0.3). Postoperative CSA, 
however, appeared similar for hernia and non-hernia patients (217.5 versus 199.3mm
2
, 
p=0.7)  
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L2-L3 Level 
Radiological assessment at L2-L3 showed that preoperative and postoperative comparison 
of all studied variables did not reveal any change in patients with or without herniation 
(Table 6.3). Similarly, the preoperative muscle CSA (250.6 versus 327.7mm
2
, p=0.6), 
muscle thickness (5.7 versus 6.0mm, p=0.9) and density (5 versus 25 Hounsfield units, 
p=0.47) were all higher in patients without herniation but the difference was not 
statistically significant. Postoperatively, muscle density was lower in patients with 
herniation (median 11 Hounsfield units, range -1-38) compared to patients without 
herniation (median 49 Hounsfield units, range 34-74; p=0.006). Postoperative CSA (269.6 
versus 231.4mm
2
, p=0.7) and thickness (5.6 versus 5.0mm, p= 0.9) were not statistically 
different between the two groups. 
 
Muscle Reconstruction 
No difference was seen in the preoperative (86.0±47.2 cm
3
) and postoperative (86.4±38.1 
cm
3
; p=0.9) muscle volume of the stoma side in patients without herniation. Muscle volume 
on the stoma side in patients with parastomal herniation was 82.7±27.1 cm
3 
and remain 
unchanged postoperatively (78.8±21.0 cm
3
; p=0.4). Comparison of the preoperative (p=0.1) 
and postoperative muscle (p=0.1) volumes of patients with and without herniation did not 
reveal any statistical difference.  
Mean muscle density on the stoma side in patients without herniation appeared reduced 
postoperatively (21.2±18.2 Hounsfield units) but unchanged compared to baseline 
(25.6±12.7 Hounsfield units; p=0.4). Patients with parastomal herniation had a significantly 
lower muscle density preoperatively (1.9±19.7 Hounsfield units) and postoperatively 
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1.7±7.3 Hounsfield units; p=0.5) but no statistical difference was found when compared  to 
the preoperative (p=0.1) and postoperative values (p=0.1) in patients without herniation.  
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Table 6.2. Relation between muscle and parastomal hernia development at T12-L1 
 
 
 
Parameter                                      Preoperative                     Postoperative                                  p-value 
 
Patients with herniation 
CSA(stoma) 292.3 (233.4-415.5) 
 
 
217.5(135.7-250.5) 
 
 
0.2 
 
 
Thickness(stoma) 6.0 (6.0-8.0) 
 
 
4.7 (3.4-7.2) 
 
 
0.2 
 
 
Density (stoma) 
 
 
29 (21-55) 
 
 
23(10-45) 
 
 
0.7 
 
 
 
Patients without herniation 
CSA(stoma) 
 
282.0 (123.3-774.4) 
 
 
199.3(109.7-605.3) 
 
 
0.5 
 
 
Thickness(stoma) 6.5 (6.0-10.2) 
 
 
6.0 (3.8-8.2) 
 
 
0.2 
 
 
Density (stoma) 
 
 
49 (14-56) 
 
 
53(25-62) 
 
 
0.7 
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Table 6.3. Relation between muscle and parastomal hernia development at L2-L3 
 
 
 
 
Parameter Preoperative          Postoperative            p-value 
Patients with herniation 
CSA(stoma) 250.6 (174.1-467.5) 
 
 
269.6(136.6-353.1) 
 
 
1.0 
 
 
Thickness(stoma) 
 
 
5.7 (4.0-7.0) 
 
 
5.6 (3.4-5.9) 
 
 
0.9 
 
 
Density (stoma) 
 
 
5 (-32-45) 
 
 
11(-1-38) 
 
 
1.0 
 
 
 
Patients without herniation 
CSA(stoma) 
 
 
327.7 (125.3-614.8) 
 
 
231.4(142.2-520.2) 
 
 
0.5 
 
 
Thickness(stoma) 
 
 
6.0 (3.1-13.0) 
 
 
5.0 (4.0-11.6) 
 
 
0.9 
 
 
Density (stoma) 
 
 
25 (-62-54) 
 
 
49(34-74) 
 
 
0.07 
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6.4 Discussion and conclusions 
This radiological study represents the first attempt, to our knowledge, to assess the structure 
of the abdominal wall musculature peri-operatively and investigate the relationship between 
rectus abdominis and parastomal hernia development. The study has revealed that cross-
sectional area, maximum thickness and maximum density decline  postoperatively although 
the differences were not statistical significant . Furthermore, muscle reconstruction did not 
demonstrate any change in muscle volume postoperatively for the rectus muscle on the 
stoma or non-stoma side. Mean muscle density appeared to decline postoperatively with a 
greater decrease seen for the rectus muscle on the stoma side although the change did not 
become statistically significant. 
A sub-analysis performed for patients with and without herniation showed that at the T12-
L1 inter-vertebral axis the cross-sectional  area and maximum thickness of the rectus 
muscle on the stoma side decreases postoperatively, albeit not statistically, for both hernia 
and non-hernia patients. However, maximum muscle density on the stoma side decreased 
slightly for patients with hernia and increased marginally in patients without herniation 
although in both cases the result was not statistically significant. Nevertheless, the 
postoperative maximum muscle density of the stoma site in patients without herniation was 
statistically higher compared to patients with a parastomal hernia. The picture was less 
clear at the L2-L3 assessment axis but the density of the rectus on the stoma side was again 
statistically higher in patients without parastomal herniation compared to patients with a 
hernia (p=0.03). Muscle reconstruction did not reveal any difference in the preoperative or 
postoperative muscle volume between patients with and without herniation but patients 
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with hernia had a significantly lower mean muscle density than those without parastomal 
herniation. 
The findings of this study are in agreement with the results of previous studies which 
reported postoperative abdominal muscle changes associated with decreased cross-sectional 
area, atrophy and degeneration.
23 26 199
 Our study has contributed to current evidence by 
demonstrating that the RA density is lower in patients with a parastomal hernia than 
patients without herniation.  This  is most likely due to postoperative infiltration of the 
muscle by adipose tissue. The reasons why certain patients have less dense abdominal 
musculature are currently unknown and may be related to patient age, gender and  lifestyle 
but a formal multivariate analysis has not performed in view of the small sample size. 
Unlike standard risk factors for parastomal hernia development (e. g. asthma, steroids, 
connective tissue disorders) muscle quality may represent and important parameter to 
identify patients who may benefit from a specific preoperative or postoperative intervention 
such as an exercise regime to improve abdominal muscle cross-sectional area, thickness 
and density.
200
 Several exercise modes (e.g. pilates, swimming) have been shown to elicit 
abdominal muscle hypertrophy and have been recommended as an effective method to 
reinforce the abdominal wall and compensate for any pre-existing asummetric 
developments.
200 201
 An exercise programme targeting the abdominal muscles of patients 
who undergo laparotomy also carries the potential benefit of improving their general 
physiological status, assisting respiratory rehabilitation and facilitating recovery since 
frailty and sarcopenia are associated with increased morbidity and mortality after major 
abdominal surgery.
194 202
 An alternative strategy may involve postoperative implantation of 
synthetic or biological scaffolds seeded with myoblasts which have been found in 
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experimental studies to promote skeletal muscle regeneration.
203 204
 One potential problem 
with such materials is that muscle growth factors and myoblasts may promote 
carcinogenesis and their use in patients undergoing stoma formation for colorectal 
malignancy is controversial.  
There are some important limitations of this work. Firstly, the study sample is small which 
may introduce a type II error. This may explain why, despite a reduction in all measurable 
variables, statistical significance was not attained. Secondly, the follow-up period  is 
limited to one year. A  longer assessment interval would be ideal as not all hernias will 
have developed during the first postoperative year. Finally, the study included only patients 
who underwent preoperative and postoperative assessment at one institution (i.e. The Royal 
London Hospital) by a single consultant radiologist. Thus, a degree of measurement or 
expectation bias cannot be excluded. This can be minimised by performing the study in 
other institutions which use different protocols of computed tomography with the scans 
being interpreted by more than one radiologist and establishing the level of inter-observer 
variability.  
In conclusion, the RA muscle density appears to decrease following major laparotomy and 
stoma formation with patients who develop a parastomal hernia having a much lower 
abdominal wall density postoperatively. Decreased postoperative muscle density may be an 
important remediable risk factor for the prevention of parastomal herniation. It is possible 
that in time, imaging may be used to predict the risk of incisional or parastomal hernia. The 
effect of a pre-operative or post-operative exercise regime on the abdominal musculature 
and the development of herniation warrants further investigation. 
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             CHAPTER 7 
      Discussion of this thesis and proposals for future work 
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Parastomal herniation has been a major surgical problem for many decades but its impact 
on quality of life and other socioeconomic issues has only been recognised more recently. 
The challenge for surgeons in the coming years is to appreciate the current status of the 
problem and acknowledge the need for change and improvement in order to reduce the 
unacceptably high incidence of herniation and avoid the continuing unsatisfactory 
outcomes associated with its repair.  
A comprehensive review of the literature performed in Chapter 1 showed that trans-
peritoneal stoma formation through the rectus muscle is safe but it is associated with 
clinical or radiological parastomal herniation rates in excess of 50%.
173 174
  There is some 
evidence, mainly level III and IV, that alternative techniques such as extra-peritoneal stoma 
formation or the lateral rectus abdominis positioned stoma (LRAPS) may reduce the 
parastomal herniation rate. A formal recommendation, however,  on the optimum technique 
for stoma formation cannot be made due to the lack of Level I evidence.  Large 
multinational randomised trials assessing the comparative efficacy of all techniques (e.g. 
extraperitoneal, LRAPS, circular devices) are urgently needed. Similarly, the literature 
review showed that there is insufficient evidence to advocate one technique for the repair of 
symptomatic parastomal hernias.
27 174
 The actual approach depends on surgeon experience, 
available resources and patient’s circumstances. Nevertheless, open or laparoscopic stoma 
reconstruction and reinforcement with a synthetic mesh seems a reasonable approach as the 
new synthetic meshes are improved in terms of biocompatibility and infectious 
complications and do not appear to be inferior to biological ones which are significantly 
more expensive. Special consideration should be given to the optimal anatomical plane for 
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mesh implantation. Future studies will need to compare the efficacy and safety of on-lay, 
sub-lay or intra-peritoneal mesh stoma reinforcement.   
At this moment in time, it is the author’s opinion that all patients, especially those at high 
risk (e.g. age> 60 years
205
, malignancy
173
), scheduled to undergo permanent stoma 
formation should be offered the option of pre-peritoneal or sublay mesh reinforcement 
since previously conducted RCTs, despite their limitations, have reported encouraging 
results without any increase in stoma-related morbidity
174
. In fact, universal stoma 
reinforcement is now routinely performed in some Northern European countries.  
Manual pre-peritoneal or sublay mesh implantation, however, is not routinely performed in 
the United Kingdom as it is thought to increase the operative time and can be particularly 
difficult if the stoma is constructed laparoscopically. Furthermore, an oversized trephine 
diameter > 25mm is, as reported in Chapter 2, a potential risk factor for herniation. The 
newly described Stapled Mesh stoma Reinforcement Technique (SMART) attempts to 
control the size of the trephine by using circular stapling devices which create a trephine< 
25mm and simplifies mesh stoma reinforcement in open or laparoscopic surgery.  The 
initial encouraging results in a highly selected patient cohort (Chapter 3) and in a sample of 
patients recruited to a large randomised controlled trial (Chapter 4) show that it reduces the 
parastomal herniation rate to approximately 15-20%. Completion of recruitment, however, 
and statistical validation the results are required prior to recommending routine use of 
SMART outside the boundaries of an RCT. Furthermore, the cost-effectiveness of 
procedure is currently unknown and the additional cost of approximately £400 for the 
stapler and the synthetic mesh may be prohibitive in the current climate of limited health 
care resources although it can potentially be “off-set” by a reduction in parastomal 
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herniation rates and cost of subsequent operations for symptomatic parastomal hernias. 
Thus, the long-term results of the trial are eagerly awaited.   
The thesis also attempted to establish the contribution of the rectus abdominis muscle in the 
development of herniation using biochemical and radiological means. Investigation of the 
expression of a novel biomarker (i.e. Mechano-Growth Factor, MGF; Chapter 5), which 
was found in previous studies to correlate with muscle injury and repair, did not show a 
differential expression intra-operatively. This may well be due to the relatively short 
operative time of a colorectal procedure not allowing quantitive changes to be detected or 
due to loss of muscle ability to regenerate following injury, especially since the median age 
of patients who underwent intra-operative biopsy was 77 years and muscle regeneration and 
repair decline with age.
185 190
  The latter explanation is a real possibility since radiological 
assessment of the rectus abdominis muscle showed a decrease in its thickness and density  
postoperatively with patients without herniation having a higher postoperative muscle 
density compared to patients with a parastomal hernia. This suggests that modification of 
the physiological characteristics of the abdominal musculature to improve its size and 
density may help reduce parastomal hernia development.  
Future research needs to address the aetiopathogenesis of parastomal hernia formation as 
until we have fully understood the mechanism of its formation, direct prevention and 
treatment will always be unsatisfactory. Two areas are likely to attract further attention as 
they have potential therapeutic implications. Firstly, identifying genetic or environmental 
factors that affect collagen metabolism since parastomal hernias, and indeed all abdominal 
wall hernias, may represent the end-point of a condition characterised by a shift in collagen 
ratio from the strong type I to the “immature” type III.11 12 Implantation of biomaterials 
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(e.g. mesh releasing Type I collagen), local administration of pharmacological adjuncts or 
gene therapy to re-adjust any imbalances in collagen metabolism may be future treatment 
strategies. Secondly, addressing the mechanics of the abdominal wall musculature and the 
role of skeletal muscle regeneration and repair is an alternative strategy with the aim to 
restore the abdominal wall to its pre-pathological mechanical state. Biological scaffolds 
seeded with muscle progenitor cells have been shown in an animal study that can be used to 
repair abdominal wall defects with regeneration of skeletal muscle tissue.
204
 Alternatively, 
the potential of biomarkers such as mechano-growth factor (MGF) to predict and 
potentially treat patients with poor abdominal wall musculature that develop herniation  
may warrant closer attention despite the negative findings of our study. An animal model 
may be a useful tool, in the first instance, to establish whether differential gene expression 
for such markers occurs in the early and late postoperative period.  Finally, electrical 
stimulation is another strategy that may be used to develop a highly differentiated and more 
functional skeletal muscle in view of the findings of experimental studies showing that 
neurotisation of engineered skeletal muscle significantly increases force generation 
compared to non-neurotised constructs.
20 206
  
In conclusion, this thesis has critically appraised current evidence on parastomal herniation 
and presented data on the safety and efficacy of a novel technique for its prevention.   It 
also explored the contribution of the rectus abdominis muscle which may be an important 
future strategy to prevent herniation.  
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                                              Appendix 1 
      EuroQol EQ-5D Health Survey   
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                                                   Appendix II 
 
 
                                   RNA isolation from human muscle tissue 
 
This section gives details for disrupting and homogenizing stabilized tissues for RNA 
purification purposes.  
 
1. Add 30-50mg of tissue to 200ul TRIZOL in a 2ml round bottomed RNAse-free 
tube. Add 2 x 5mm stainless steel beads and place in tissue lyser (with balance) and 
shake for 2 minutes at 25Hz. 
2. Remove beads and add 800ul TRIZOL. 
3. Add 200μl 2-bromo-3-chloropropanol (chloroform, Sigma-Aldrich) (per ml 
TRIZOL) to the homogenised tissue and shake for 15s.  
4. Transfer the homogenate (1ml aliquots) into an appropriate number of pre-spun 
(13,000 rpm for 30s) phase lock gel 2ml tubes Incubate at room temperature for 3 
minutes.  
5. Centrifuge (using centrifuge in the cold room) at 11,800rpm for 15 minutes.  
6. Remove clear aqueous upper phase into a new RNAse-free eppendorf tube. 
7. Add 500ul 2-propanol (Sigma-Aldrich), invert to mix and incubate at room 
temperature for 10minutes. 
8. Centrifuge (using centrifuge in the cold room) at 11,800rpm for 10 minutes.  
9. Discard supernatant carefully as not to disrupt or remove pellet. The pellet is 
sometimes difficult to see and appears as a smear on the side of the tube.  
10. Wash pellet with 1ml 75% Ethanol (Sigma-Aldrich)/H2O and vortex. 
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11. Centrifuge at 9,200 rpm for 5 minutes  
12. Remove supernatant and air dry for 5minutes. Add 10ul RNAase-free H2O and 
quantify using NanoDrop
®
.  
13. Record RNA concentration on the tube and on the record sheet.  
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         Appendix III 
                  Reverse transcription protocol using OmniScript Reverse  
                                         Transcriptase Kit (Qiagen, UK) 
The QIAGEN reverse transcriptase kit contains Omniscript reverse transcriptase, x10 
buffer RT, dNTP (5mM) and RNA free water. RNase inhibitor (Recombinant RNasin 
Ribonuclease inhibitor (Promega-N2511) and oligo-dT primers (oligo dT15 primer 
(Promega-C1101) were supplied separately.  The components are mixed to create a 20μl 
solution as listed in the table below:  
Component 
 
Volume/reaction Final concentration 
 
X10 Buffer RT 2 l X1 
dNTP (5mM) 
Oligo dT15 (10 M) 
2 l 
2 l 
0.5mM each dNTP 
1 M 
RNasin inhibitor (40u/ l) 0.1 l 4 units 
Omniscript RT 1 l 4 units 
Master Mix volume 7.10 l  
   
RNA Template Variable*  
RNase-free water Variable*  
Sample volume 12.9ul  
Total reaction volume 20 l  
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Procedure 
1. Thaw the RNA template, the primer solutions, 10x Buffer RT, dNTP Mix and 
RNase-free water at room temperature (15–25°C). Store on ice immediately after 
thawing.  Mix each solution by vortexing and centrifuge briefly to collect residual 
liquid from the sides of the tubes. 
2. Commercially available RNase inhibitor is commonly supplied at 40 units/μl. Dilute 
the RNase inhibitor to a final concentration of 10 units/μl in ice-cold 1x Buffer RT 
(dilute an aliquot of 10x Buffer RT accordingly using the RNase-free water 
supplied). Mix carefully by vortexing for no more than 5 seconds, and centrifuge 
briefly to collect residual liquid from the sides of the tube.  
3.  Prepare a fresh master mix on ice according to the table above. Mix thoroughly and 
carefully by vortexing for no more than 5 seconds. Centrifuge briefly to collect 
residual liquid from the walls of the tube, and store on ice.  
4. Once RNA has been extracted and quantified, determine the volume of sample in l 
required for 1 g of total RNA.  Add template RNA to the individual tubes 
containing the master mix. Mix thoroughly   and carefully by vortexing for no more 
than 5 seconds. Centrifuge briefly to collect residual liquid from the walls of the 
tubes. 
5. Incubate for 60 min at 37°C. 
6. Store reverse- transcription reactions on ice and proceed directly with PCR, or for 
long-term storage, store reverse- transcription reactions  at   – 20°C. 
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                                                  Appendix IV 
 
 
                                   Generation of qPCR standards 
Component 
 
Volume/reaction Final concentration 
 
HotStarTaq Master Mix 12.5 l 2.5u HST DNA polymerase 
1.5mM MgCl2 
 
 
 
 
200 M each dNTP 
x1 PCR buffer 
Forward primer (10uM stock) 0.75 l 300nM 
Reverse primer (10uM stock) 0.75 l 300nM 
Distilled 7.5 l  
Master Mix volume 21.5 l  
   
cDNA template  (100ng) 3.5 l  
Total reaction volume 25 l  
 
When using HotStarTaq Master Mix, each PCR program must start with an initial heat activation 
step at 95 C for 15 min. The reactions conditions are as follows: 
Initial activation step 15 min @ 95 C 
Denaturation 1 min @ 94 C 
Annealing 1 min @ 60 C 
Extension 2 min @ 72 C 
Number of cycles ~ 35 
Final extension 10 min @ 72 C and hold at 4 C 
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                                                           Appendix V  
                     Gel extraction and purification of RT-PCR product 
1. Excise DNA fragment from the agarose gel with a clean sharp scalpel. 
 
2. Weigh the gel slice in a colourless tube. Add 3 volumes of buffer QG to 1 volume of 
the gel e.g. 300ul buffer to 100mg of gel. 
 
3. Incubate at 50oC for 10 min (or until the slice has completely dissolved). Mix by 
vortexing the tube every 2-3 minutes. 
 
4. Check that the colour of the mixture is still yellow. If the colour is orange or violet, 
add 10ul of 3M sodium acetate. 
 
5. Add 1 gel volume of isopropanol to the sample and mix. e.g.  if gel sample was 
100mg add 100ul. 
 
6. Place QIAquick spin column in a 2ml collection tube. Apply 800ul sample mix to 
column and centrifuge for 1 minute @ 13,000rpm. Discard flow-through. For any 
remaining sample, load and spin again. 
 
7. Add 500ul of buffer QG to column and centrifuge for 1 minute at 13,000rpm. 
 
8. Add 750ul of buffer PE to column and centrifuge for 1 minute @ 13,00rpm. 
 
9. Discard flow-through and centrifuge for 1 minute @ 13,000rpm. 
 
10. Place QIAquick column in a 1.5ml micro centrifuge tube. Add 30ul buffer EB to the 
centre of the membrane and centrifuge for 1 minute@13, 000rpm. Quantify DNA 
using the NanoDrop. 
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                                                    Appendix VI 
                                  Calculation of gene copy number 
Firstly, the molecular weight (MW) of a PCR gene product of size A bp must be calculated.  
The average MW of a dNTP (A, T, G, C) = 330 Da.  
As the cDNA product is double stranded, the dNTP MW = 660 Da. (This calculation is 
based on the assumption that there is an equal number of all bases in the product).  
The MW of PCR product B = average dNTP MW x A bp of PCR product. 
B = 660 x A 
Now the number of copies of PCR product in 1ng is calculated: 
Avocadro’s constant = 6.02x1023 molecules in 1 mole and is equal to molecular weight in 
grams. 
 B grams of gene product = 6.02x10
23
 molecules. 
  1ng = 10
-9 
g 
Therefore, in 1ng of gene product there is = 6.02x1023B×10-9= C copies. 
Lastly, the number of copies of PCR product in 1 μl is calculated using the concentration 
recorded from the Nanodrop-1000 spectrophotometer:  
There is C copies in 1ng of gene product.   
 
The concentration of cDNA in a sample is D ng/μl 
Therefore, number of copies in 1ng x cDNA concentration = E copies/μl 
C x D = E 
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